Processing 00000000.tx.1: Journal of Histochemistry and Cytochemistry, Vol. 

Phrase: "Journal of Histochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0162443:Journal [Intellectual Product,Manufactured Object]

Phrase: "and"

Phrase: "Cytochemistry,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010741:Cytochemistry [Biomedical Occupation or Discipline]

Phrase: "Vol."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0449468:VOL [Quantitative Concept]
  1000   C0560268:vol% [Quantitative Concept]
  1000   C1690016:% vol [Qualitative Concept]
Processing 00000000.tx.2: 51, 1201-1206, September 2003, Copyright  2003, The Histochemical Society, Inc. 

Phrase: "51,"

Phrase: "1201-1206,"

Phrase: "September 2003,"

Phrase: "Copyright  2003,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0009993:Copyright [Intellectual Product]
   861   C1552856:copyright [Idea or Concept]

Phrase: "The Histochemical Society,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0037455:society [Organization]

Phrase: "Inc."
Processing 00000000.tx.3: ARTICLE Triple Immunofluorolabeling with Two Rabbit Polyclonal Antibodies and a Mouse Monoclonal Antibody Allowing Three-dimensional Analysis of Cotton Wool Plaques in Alzheimer Disease Toshiki Uchiharaa, Ayako Nakamuraa, Hiroshi Nakayamac, Kunimasa Arimad, Norio Ishizukab, Hiroshi Morie, and Setsuo Mizushimaf a Departments of Neuropathology, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan b Brain Structure, Tokyo Metropolitan Institute for Neuroscience, Tokyo, Japan c Department of Psychiatry, Tokyo Metropolitan Neurological Hospital, Tokyo, Japan d Department of Laboratory Medicine, National Center Hospital for Mental, Nervous, and Muscular Disorders, National Center for Neurology and Psychiatry, Tokyo, Japan e Department of Neuroscience, Osaka City University School of Medicine, Osaka, Japan f Mizushima Clinic, Tokyo, Japan Correspondence to: Toshiki Uchihara, Dept. of Neuropathology, Tokyo Metropolitan Institute for Neuroscience, 2-6 Musashi-dai, Fuchu, Tokyo 183-8526, Japan. 

Phrase: "ARTICLE Triple Immunofluorolabeling with Two Rabbit Polyclonal Antibodies"

Phrase: "and"

Phrase: "a Mouse Monoclonal Antibody Allowing Three-dimensional Analysis of Cotton Wool Plaques"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0002778:Analysis [Laboratory Procedure]
   736   C0936012:Analysis [Research Activity]
   736   C1524024:analysis [Functional Concept]

Phrase: "in Alzheimer Disease Toshiki Uchiharaa,"

Phrase: "Ayako Nakamuraa,"

Phrase: "Hiroshi Nakayamac,"

Phrase: "Kunimasa Arimad,"

Phrase: "Norio Ishizukab,"

Phrase: "Hiroshi Morie,"

Phrase: "and"

Phrase: "Setsuo Mizushimaf"

Phrase: "a Departments of Neuropathology,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   802   C0587493:Neuropathology department [Health Care Related Organization]
   737   C1704729:Department [Organization]

Phrase: "Tokyo Metropolitan Institute for Neuroscience,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan b Brain Structure,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0006104:Brain structure [Body Part, Organ, or Organ Component]
           Brain
   812   C0678594:Structure [Spatial Concept]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "Tokyo Metropolitan Institute for Neuroscience,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan c Department of Psychiatry,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   797   C0587494:Psychiatry department [Health Care Related Organization]
   760   C1704729:Department [Organization]

Phrase: "Tokyo Metropolitan Neurological Hospital,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   875   C0020029:Metropolitan Hospital [Health Care Related Organization]
   812   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   812   C1510665:Hospital [Qualitative Concept]
   729 E C1609061:Hospitals [Intellectual Product]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan d Department of Laboratory Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1704729:Department [Organization]

Phrase: "National Center Hospital for Mental, Nervous,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0020021:Mental hospital [Health Care Related Organization,Manufactured Object]
   753   C0019994:Hospital, NOS [Health Care Related Organization,Manufactured Object]
   753   C1510665:Hospital [Qualitative Concept]

Phrase: "and"

Phrase: "Muscular Disorders,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0026848:Muscular Disorders [Disease or Syndrome]
   861   C0012634:Disorders [Disease or Syndrome]

Phrase: "National Center for Neurology"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205099:Center [Spatial Concept]

Phrase: "and"

Phrase: "Psychiatry,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0033872:Psychiatry [Professional or Occupational Group]
  1000   C0033873:Psychiatry [Biomedical Occupation or Discipline]
   928 E C0205487:Psychiatric [Functional Concept]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan e Department of Neuroscience,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1704729:Department [Organization]

Phrase: "Osaka City University School of Medicine,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0036375:School [Manufactured Object,Organization]

Phrase: "Osaka,"

Phrase: "Japan f Mizushima Clinic,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0002424:Clinic [Health Care Related Organization,Manufactured Object]
   812   C0442592:Clinic [Health Care Related Organization,Manufactured Object]
   741 E C0205210:Clinical [Qualitative Concept]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan Correspondence to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0282413:Correspondence [Intellectual Product]

Phrase: ":"

Phrase: "Toshiki Uchihara,"

Phrase: "Dept."

Phrase: "of Neuropathology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0876934:Neuropathology [Biomedical Occupation or Discipline]
  1000   C1540677:neuropathology [Pathologic Function]
  1000   C1555824:Neuropathology [Intellectual Product]

Phrase: "Tokyo Metropolitan Institute for Neuroscience,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0021622:institute [Organization]
   760   C1272753:Institute [Idea or Concept]

Phrase: "2-6 Musashi-dai,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0683432:DAI [Intellectual Product]
   812   C1424053:DAI [Gene or Genome]

Phrase: "Fuchu,"

Phrase: "Tokyo 183-8526,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0040371:Tokyo [Geographic Area]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.4: E-mail: uchihara@tmin.ac.jp Summary Top Summary Introduction Materials and Methods Results Discussion Literature Cited We established a triple-labeling method with two rabbit polyclonal antibodies and a mouse monoclonal antibody and examined autopsied brain tissue with cotton wool plaques (CWPs). 

Phrase: "E-mail"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]
   861   C0024492:Mail [Manufactured Object]
   861   C1538057:MAIL [Gene or Genome]
   861   C1547565:Mail [Idea or Concept]

Phrase: ":"

Phrase: "uchihara@tmin.ac.jp Summary Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   791   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "We"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "a triple-labeling method with two rabbit polyclonal antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "a mouse monoclonal antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "and"

Phrase: "examined autopsied brain tissue with cotton wool plaques (CWPs)."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0440746:Brain tissue [Tissue]
   770   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   750   C0332461:Plaque Tissue [Finding]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0040300:Tissue [Tissue]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.5: One of the polyclonal antibodies was so diluted (anti-A42 or anti-A40/1:30,000 or anti-von Willebrand factor/1:1000) that its visualization was possible only after amplification with the catalyzed reporter deposition (CARD) method. 

Phrase: "One of the polyclonal antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "(anti-A42"

Phrase: "or"

Phrase: "anti-A40/1"

Phrase: ":"

Phrase: "30,000"

Phrase: "or"

Phrase: "anti-von Willebrand factor/1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0042971:von Willebrand Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   884   C1336938:VON WILLEBRAND FACTOR [Gene or Genome]
   840   C0042974:von Willebrand [Disease or Syndrome]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "that"

Phrase: "its visualization"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0175631:Visualization [Mental Process]
  1000   C2827662:Visualization [Occupation or Discipline]

Phrase: "was"

Phrase: "possible only"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0205171:Only [Quantitative Concept]
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C1720467:Only [Intellectual Product]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "after"

Phrase: "amplification with the catalyzed reporter deposition (CARD) method."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.6: The other polyclonal antibody (anti-A40 or anti-A42/1:1000) was visualized with a fluorochrome conjugated to an anti-rabbit antibody that specifically visualized the latter polyclonal antibody because of its lower sensitivity. 

Phrase: "The"

Phrase: "other polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-A40"

Phrase: "or"

Phrase: "anti-A42/1"

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "was"

Phrase: "visualized with a fluorochrome"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]
   770   C0234621:Visualized [Functional Concept]

Phrase: "conjugated to an anti-rabbit antibody"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0034493:Rabbit [Mammal]
   753   C0522529:Conjugated [Spatial Concept]
   719 E C0301869:Conjugate [Immunologic Factor]

Phrase: "that specifically"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "the latter polyclonal antibody because of its lower sensitivity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   764   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   742   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.7: A monoclonal antibody, AT8, was superimposed to yield triple immunofluorolabeling. 

Phrase: "A monoclonal antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "AT8,"

Phrase: "was"

Phrase: "superimposed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "yield"

Phrase: "triple immunofluorolabeling."
Processing 00000000.tx.8: Serial optical sections with an interval of 0.3 m were reconstructed to allow three-dimensional (3D) observation of these three epitopes. 

Phrase: "Serial optical sections with an interval of 0.3 m"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   706   C0205155:Section [Spatial Concept]
   706   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   706   C1522472:Section [Substance]
   706   C1552923:Section [Quantitative Concept]
   706   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "reconstructed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2348043:Reconstructed [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "allow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "three-dimensional"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0450363:3-Dimensional [Spatial Concept]
   861   C0205449:Three [Quantitative Concept]
   789   C0439534:Dimension [Quantitative Concept]
   789   C1707753:Dimensionality [Spatial Concept]

Phrase: "(3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: ")"

Phrase: "observation of these three epitopes."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0302523:Observation [Research Activity]
   760   C0700325:observation [Health Care Activity]
   760   C1964257:Observation [Diagnostic Procedure]
Processing 00000000.tx.9: A40 was localized to core-like structures, mainly in layers IIII, and was sometimes in contact with the vascular wall, both without neuritic reactions. 

Phrase: "A40"

Phrase: "was"

Phrase: "localized to core-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0392752:Localized [Spatial Concept]
   790   C0444669:Core [Spatial Concept]
   790   C1167518:core [Cell Component]
   790   C1706352:Core [Medical Device]
   790   C1882467:Core [Manufactured Object]
   790   C3274653:Core [Body Substance]

Phrase: "like structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "mainly in layers IIII,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C0934502:layers [Body Part, Organ, or Organ Component]
   737 E C1522408:Layer [Qualitative Concept]
   737 E C1561599:Layer [Intellectual Product]

Phrase: "and"

Phrase: "was"

Phrase: "sometimes in contact with the vascular wall,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   778   C0332158:Contact with [Functional Concept]
           contact
   751   C1180033:Blood vessel wall [Body Part, Organ, or Organ Component]
   748   C0005847:vascular [Body Part, Organ, or Organ Component]
   748   C0337611:Contact [Population Group]
   748   C0677535:Wall [Manufactured Object]
   748   C1558950:VASCULAR [Finding]
   748   C1705415:Contact [Idea or Concept]
   748   C1801960:Vascular [Qualitative Concept]
   748   C1998882:Sometimes [Temporal Concept]

Phrase: "both without neuritic reactions."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0238767:Both [Spatial Concept]
   770   C1706086:Both [Qualitative Concept]
   737   C0443286:Reaction [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.10: CWPs, present in layers IVI, were labeled with anti-A42 and were accompanied by neuritic reactions. 

Phrase: "CWPs,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   734   C0440207:Cotton wool [Biomedical or Dental Material]

Phrase: "present in layers IVI,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0150312:Present [Quantitative Concept]
   770   C0449450:Present [Idea or Concept]

Phrase: "were"

Phrase: "labeled with anti-A42"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   770   C1708632:Labeled [Qualitative Concept]
   737 E C0181496:Label [Manufactured Object]
   737 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "and"

Phrase: "were"

Phrase: "accompanied by neuritic reactions."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   737   C0443286:Reaction [Functional Concept]
   737   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.11: These differences suggest that mechanisms of A deposition and its relation to neuritic reactions or to blood vessels differ according to the lesion, even in the same microscopic field. 

Phrase: "These differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mechanisms of A deposition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0441712:Mechanisms [Functional Concept]
   726 E C1706376:Mechanism [Manufactured Object]

Phrase: "and"

Phrase: "its relation to neuritic reactions"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0080103:Relation [Family Group]
   760   C0869014:relation [Social Behavior]

Phrase: "or to blood vessels"
Meta Candidates (Total=12; Excluded=10; Pruned=0; Remaining=2)
   833   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   799 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   799 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
   740 E C0005767:Blood [Tissue]
   740 E C0005768:blood [Body Substance]
   740 E C0229664:Blood [Body Substance]
   740 E C0392895:Bloods [Population Group]
   722 E C0333275:Bloody [Qualitative Concept]

Phrase: "differ according to the lesion,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0221198:Lesion [Finding]
   760   C0680240:according [Social Behavior]
   760   C1546698:Lesion [Intellectual Product]

Phrase: "even in the same microscopic field."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205288:Microscopic [Qualitative Concept]
   753   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   753   C0445247:Same [Qualitative Concept]
   753   C1521738:Field [Conceptual Entity]
   753   C2346620:Field [Conceptual Entity]
   753   C2349184:Field [Conceptual Entity]
   753   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.12: (J Histochem Cytochem 51:12011206, 2003) Key Words: triple immunofluorescence, three dimensions, reconstruction, laser confocal microscopy, amyloid, A42, cotton wool plaques Introduction Top Summary Introduction Materials and Methods Results Discussion Literature Cited THE COTTON WOOL PLAQUE (CWP) is a peculiar type of senile plaque seen in brains of some patients with familial Alzheimer disease (AD) and in those of sporadic AD. 

Phrase: "(J Histochem Cytochem 51"

Phrase: ":"

Phrase: "12011206,"

Phrase: "2003"

Phrase: ")"

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "triple immunofluorescence,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "three dimensions,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   958   C0450363:Three-dimensional [Spatial Concept]
   861   C0439534:Dimensions [Quantitative Concept]
   755 E C1707753:Dimensionality [Spatial Concept]

Phrase: "reconstruction,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020912:Reconstruction [Machine Activity]
  1000   C0524865:Reconstruction [Therapeutic or Preventive Procedure]

Phrase: "laser confocal microscopy,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   913   C0600395:Laser Microscopy [Laboratory Procedure]
   901   C0242842:Microscopy, Confocal [Laboratory Procedure]
   827   C0026018:Microscopy [Laboratory Procedure]
   755 E C0205288:Microscopic [Qualitative Concept]

Phrase: "amyloid,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0011560:Amyloid [Pathologic Function]
  1000   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "A42,"

Phrase: "cotton wool plaques Introduction Top Summary Introduction Materials"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   880   C0440207:Cotton wool material [Biomedical or Dental Material]
   875   C1095832:Cotton material [Substance]
   793   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "THE COTTON WOOL PLAQUE (CWP)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0011389:Plaque [Disease or Syndrome]
   827   C0332461:Plaque [Finding]
   827   C0333463:plaque [Acquired Abnormality]
   734   C0440207:Cotton wool [Biomedical or Dental Material]

Phrase: "is"

Phrase: "a peculiar type of senile plaque"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0332307:Type [Qualitative Concept]
   753   C1547052:*Type [Quantitative Concept]

Phrase: "seen in brains of some patients"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   753   C0006104:Brains [Body Part, Organ, or Organ Component]
   753   C0030705:Patients [Patient or Disabled Group]
   753   C0205397:Seen [Qualitative Concept]
   719 E C0042789:see [Organism Function]
   719 E C1269537:Brain [Body Part, Organ, or Organ Component]
   719 E C1947903:See [Activity]

Phrase: "with familial Alzheimer disease (AD)"
Meta Candidates (Total=12; Excluded=5; Pruned=0; Remaining=7)
  1000   C0276496:Alzheimer disease, familial [Disease or Syndrome]
   913   C0277558:Familial disease [Disease or Syndrome]
   901   C0002395:Alzheimer's Disease [Disease or Syndrome]
   901   C1521724:Alzheimer's Disease [Pathologic Function]
   877 E C0344339:family disease [Finding]
   827   C0012634:Disease [Disease or Syndrome]
   827   C0015576:familial [Family Group]
   827   C0241888:Familial [Functional Concept]
   771 E C1836721:MALS [Finding]
   771 E C3538764:MALS [Gene or Genome]
   771 E C3540595:MAL [Gene or Genome]
   755 E C1704727:Family [Conceptual Entity]

Phrase: "and in those of sporadic AD."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0002395:Alzheimer's Disease [Disease or Syndrome]
   778   C1521724:Alzheimer's Disease [Pathologic Function]
   748   C0012634:Disease [Disease or Syndrome]
   748   C0205422:Sporadic [Temporal Concept]
   748   C1515981:And [Idea or Concept]
Processing 00000000.tx.13: CWPs are characterized by robust deposition of amyloid  protein (A), A42 (Crook et al. 1998 ; Le et al. 2001 ; Steiner et al. 2001 ; Verkkoniemi et al. 2001 ; Tabira et al. 2002 ), a longer molecular species of A, possibly involved in early phase of A deposition (Iwatsubo et al. 1994 ). 

Phrase: "CWPs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   734   C0440207:Cotton wool [Biomedical or Dental Material]

Phrase: "are"

Phrase: "characterized by robust deposition of amyloid  protein (A"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   789   C0002722:Amyloid A Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   770   C1456454:Amyloid protein [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   767   C0002723:Amyloid A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0011560:Amyloid deposition [Pathologic Function]
           Amyloid
   767   C0333584:Protein deposition [Pathologic Function]
   767   C1705760:Amyloid Deposition [Finding]
   744   C0002716:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0333562:Deposition [Functional Concept]
   744   C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C1880022:Characterized [Activity]
   744   C2986815:Robust [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "A42"

Phrase: "(Crook et al. 1998"

Phrase: "; Le et al. 2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439090:LE [Idea or Concept]
   812   C1423767:LE [Gene or Genome]

Phrase: "; Steiner et al. 2001"

Phrase: "; Verkkoniemi et al. 2001"

Phrase: "; Tabira et al. 2002"

Phrase: ")"

Phrase: ","

Phrase: "a longer molecular species of A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1705920:Species [Conceptual Entity]

Phrase: "possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2362652:Possibly [Qualitative Concept]

Phrase: "involved in early phase of A deposition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0205390:Phase [Temporal Concept]
   748   C0333562:Deposition [Functional Concept]
   748   C1279919:Early [Temporal Concept]
   748   C1314939:Involved [Functional Concept]

Phrase: "(Iwatsubo et al. 1994"

Phrase: ")."
Processing 00000000.tx.14: Although its shorter counterpart A40 is also another major constituent of senile plaques, the spatial relationship between these A species and other components is of particular interest because deposition of each A species is considered to occur at different stages of senile plaque formation (Iwatsubo et al. 1994 ). 

Phrase: "Although"

Phrase: "its shorter counterpart A40"

Phrase: "is"

Phrase: "also"

Phrase: "another major constituent of senile plaques,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0729650:constituent [Substance]

Phrase: "the spatial relationship between these"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "and"

Phrase: "other components"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449432:Components [Manufactured Object]
   966 E C1705248:Component [Conceptual Entity]

Phrase: "is of particular interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0543488:Interest [Mental Process]

Phrase: "because"

Phrase: "deposition of each"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333562:Deposition [Functional Concept]

Phrase: "A species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705920:Species [Conceptual Entity]

Phrase: "is"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "occur at different stages of senile plaque formation"
Meta Candidates (Total=15; Excluded=2; Pruned=0; Remaining=13)
   800   C1849249:SENILE PLAQUE FORMATION [Pathologic Function]
   770   C0333463:Senile plaque [Acquired Abnormality]
           plaque
   744   C0011389:Plaque [Disease or Syndrome]
   744   C0220781:formation [Biologic Function]
   744   C0332461:Plaque [Finding]
   744   C0392079:Senile [Finding]
   744   C0439634:formation [Spatial Concept]
   744   C1306673:Stages [Qualitative Concept]
   744   C1522492:Formation [Functional Concept]
   744   C1705242:Different [Qualitative Concept]
   744   C1709305:Occur [Activity]
   744   C2745955:OCCUR [Temporal Concept]
   711 E C0205390:Stage [Temporal Concept]
   711 E C1300072:Stage [Clinical Attribute]

Phrase: "(Iwatsubo et al. 1994"

Phrase: ")."
Processing 00000000.tx.15: By immunizing rabbits, one of the authors (HM) has generated anti-A antibodies, each of which specifically reacts with either A42 or A40 (Akiyama et al. 1997 ). 

Phrase: "By immunizing rabbits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034493:Rabbit [Mammal]

Phrase: "one of the authors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "(HM"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0262500:hm [Health Care Activity]
  1000   C1512358:HM [Geographic Area]
  1000   C3538713:HM [Idea or Concept]

Phrase: ")"

Phrase: "has"

Phrase: "generated anti-A antibodies,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   875   C1624602:Anti-Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   858 E C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "each of which specifically"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1457900:Each [Quantitative Concept]

Phrase: "reacts with either A42"

Phrase: "or"

Phrase: "A40"

Phrase: "(Akiyama et al. 1997"

Phrase: ")."
Processing 00000000.tx.16: We wanted to examine the spatial relationship between these two epitopes specifically detectable with these antibodies by using multi-labeling immunohistochemistry (Van der Loos et al. 1989 ; Uchihara et al. 1995 , Uchihara et al. 2000 ). 

Phrase: "We"

Phrase: "wanted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1444647:Wanted [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "the spatial relationship between these two epitopes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "specifically detectable with these antibodies"

Phrase: "by"

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "multi-labeling immunohistochemistry"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0021044:Immunohistochemistry [Laboratory Procedure]

Phrase: "(Van der Loos et al. 1989"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557775:Van [Manufactured Object]
   799   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "; Uchihara et al. 1995 ,"

Phrase: "Uchihara et al. 2000"

Phrase: ")."
Processing 00000000.tx.17: One of the obstacles was that the antibodies to be applied on the same sections were from the same species, which usually hampers multilabeling. 

Phrase: "One of the obstacles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "that"

Phrase: "the antibodies to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "be"

Phrase: "applied on the same sections"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0185125:Applied [Health Care Activity]
   760   C0445247:Same [Qualitative Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726 E C1632850:Apply [Functional Concept]
   726   C1705191:Section [Physical Object]
   726 E C1879355:Apply [Functional Concept]

Phrase: "were from the same species,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0445247:Same [Qualitative Concept]
   760   C1705920:Species [Conceptual Entity]

Phrase: "which usually"

Phrase: "hampers"

Phrase: "multilabeling."
Processing 00000000.tx.18: Several procedures have been proposed to circumvent this difficulty, with some success. 

Phrase: "Several procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "have"

Phrase: "been"

Phrase: "proposed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1441414:PROPOSED [Idea or Concept]
  1000   C1553874:Proposed [Qualitative Concept]
  1000   C1578820:Proposed [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "circumvent"

Phrase: "this difficulty,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1299586:Difficulty [Finding]
   928 E C0332218:Difficult [Qualitative Concept]

Phrase: "with some success."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0597535:Success [Social Behavior]
   928 E C1272703:Successful [Qualitative Concept]
Processing 00000000.tx.19: For example, conjugation of enzyme, biotin, or fluorochrome to one of the primary antibodies allows separate detection of the two antibodies, but it requires a relatively large amount of the antibody and the conjugation procedure can be cumbersome (Van der Loos et al. 1989 ; Uchihara et al. 1995 ). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "conjugation of enzyme,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C1160466:conjugation [Cell Function]
   718 E C0522529:Conjugated [Spatial Concept]

Phrase: "biotin,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C2700256:Biotin [Laboratory Procedure]

Phrase: "or"

Phrase: "fluorochrome to one of the primary antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]

Phrase: "allows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0683607:allow [Social Behavior]

Phrase: "separate detection of the two antibodies,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   783   C0430425:antibodies detection [Laboratory Procedure]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "but"

Phrase: "it"

Phrase: "requires"

Phrase: "a relatively large amount of the antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "and"

Phrase: "the conjugation procedure"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C1948041:Procedure [Therapeutic or Preventive Procedure]
   861   C2700391:Procedure [Activity]
   861   C3274430:PROCEDURE [Health Care Activity]
   861   C3538935:Procedure [Idea or Concept]
   861   C3539779:Procedure [Intellectual Product]

Phrase: "can"

Phrase: "be"

Phrase: "cumbersome"

Phrase: "(Van der Loos et al. 1989"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0557775:Van [Manufactured Object]
   799   C1511780:der [Cell or Molecular Dysfunction]

Phrase: "; Uchihara et al. 1995"

Phrase: ")."
Processing 00000000.tx.20: Another approach is to wash out the bound antibodies with glycine buffer at very low pH after the first cycle of immunodetection (Nakane 1968 ). 

Phrase: "Another approach"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449445:Approach [Spatial Concept]

Phrase: "is to wash out"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0439787:Out [Spatial Concept]
   770   C0441648:Wash [Activity]
   770   C0849355:Out [Qualitative Concept]

Phrase: "the bound antibodies with glycine buffer"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   719 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "at very low pH"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   901   C0442811:Very low [Finding]
   901   C0728725:Low pH [Finding]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0205251:low [Qualitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]
   827   C1299352:Low [Qualitative Concept]
   827   C1550472:low [Idea or Concept]

Phrase: "after the first cycle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1511572:Cycle [Temporal Concept]

Phrase: "of immunodetection"

Phrase: "(Nakane 1968"

Phrase: ")."
Processing 00000000.tx.21: Treatment in a microwave oven after the color development of the first primary antibody has been reported to be effective in avoiding crossreaction (Lan et al. 1995 ). 

Phrase: "Treatment in a microwave oven"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "after the color development"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: "of the first primary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "effective in avoiding crossreaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1280519:effective [Qualitative Concept]
   770   C1704419:Effective [Qualitative Concept]

Phrase: "(Lan et al. 1995"

Phrase: ")."
Processing 00000000.tx.22: Although these sequential procedures are generally successful in detecting non-co-localizing epitopes, they are not applicable for multiple immunofluorescence labeling. 

Phrase: "Although"

Phrase: "these sequential procedures"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   861   C0025664:procedures [Intellectual Product]
   861   C0184661:Procedures [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   861   C2700391:procedures [Activity]
   827 E C1948041:Procedure [Therapeutic or Preventive Procedure]
   827 E C3274430:PROCEDURE [Health Care Activity]
   827 E C3538935:Procedure [Idea or Concept]
   827 E C3539779:Procedure [Intellectual Product]

Phrase: "are"

Phrase: "generally successful in detecting non-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1272703:Successful [Qualitative Concept]

Phrase: "co-localizing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0392752:localizing [Spatial Concept]

Phrase: "epitopes,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0003316:Epitopes [Immunologic Factor]

Phrase: "they"

Phrase: "are"

Phrase: "not applicable for multiple immunofluorescence labeling."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1272460:Not Applicable [Qualitative Concept]
           applicable
   753   C1706839:Applicable [Qualitative Concept]
Processing 00000000.tx.23: A previous study demonstrated that double immunofluorolabeling with two antibodies from the same species was possible with extensive blockade with F(ab')2 fragment (Lewis-Carl et al. 1993 ) between the two primary antibodies. 

Phrase: "A previous study"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "demonstrated"

Phrase: "that double immunofluorolabeling with two antibodies"

Phrase: "from the same species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1705920:Species [Conceptual Entity]

Phrase: "was"

Phrase: "possible with extensive blockade"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332149:Possible [Qualitative Concept]
   770   C1705910:Possible [Qualitative Concept]
   770   C2362652:Possible [Qualitative Concept]

Phrase: "with F(ab')2 fragment"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0332255:fragment [Functional Concept]
   812   C1708096:Fragment [Qualitative Concept]

Phrase: "(Lewis-Carl et al. 1993"

Phrase: ")"

Phrase: "between the two primary antibodies."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.24: However, double labeling with this method was associated with a significant decrease in the sensitivity of one of the primary antibodies applied after this extensive blocking. 

Phrase: "However,"

Phrase: "double labeling with this method"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205173:Double [Functional Concept]
   760   C1167624:Labeling [Mental Process]
   760   C1705764:Double [Activity]
   760   C1705765:Double [Qualitative Concept]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]
   726 E C0181496:Label [Manufactured Object]

Phrase: "was"

Phrase: "associated with a significant decrease"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0237881:significant [Quantitative Concept]
   760   C0392756:Decrease [Qualitative Concept]
   760   C0547047:Decrease [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1546944:Significant [Qualitative Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]

Phrase: "in the sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
  1000   C0036667:Sensitivity [Quantitative Concept]
  1000   C0312418:Sensitivity [Mental Process]
  1000   C0427965:Sensitivity [Finding]
  1000   C1511883:Sensitivity [Quantitative Concept]
  1000   C1522640:Sensitivity [Qualitative Concept]
  1000   C2346484:SENSITIVITY [Phenomenon or Process]
  1000   C2349185:Sensitivity [Qualitative Concept]
   928 E C0332324:Sensitive [Functional Concept]
   928 E C1550474:sensitive [Idea or Concept]

Phrase: "of one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of the primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "applied after this extensive blocking."
Meta Candidates (Total=10; Excluded=6; Pruned=0; Remaining=4)
   760   C0185125:Applied [Health Care Activity]
   760   C0205231:Extensive [Qualitative Concept]
   760   C0233660:Blocking [Mental or Behavioral Dysfunction]
   760   C0332206:Blocking [Functional Concept]
   726 E C0028778:Block [Pathologic Function]
   726 E C1533157:Block [Substance]
   726 E C1632850:Apply [Functional Concept]
   726 E C1706084:Block [Geographic Area]
   726 E C1879355:Apply [Functional Concept]
   726 E C2828370:Block [Quantitative Concept]
Processing 00000000.tx.25: This trade-off of double labeling with decreased sensitivity was circumvented when one of the antibodies was amplified (Hunyady et al. 1996 ) with the catalyzed reporter amplification method (CARD). 

Phrase: "This trade-off of double labeling"

Phrase: "with decreased sensitivity"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
  1000   C0020580:Decreased Sensitivity [Finding]
  1000   C1880261:DECREASED SENSITIVITY [Phenomenon or Process]
  1000   C2348085:DECREASED SENSITIVITY [Phenomenon or Process]
   861   C0036667:Sensitivity [Quantitative Concept]
   861   C0312418:Sensitivity [Mental Process]
   861   C0427965:Sensitivity [Finding]
   861   C1511883:Sensitivity [Quantitative Concept]
   861   C1522640:Sensitivity [Qualitative Concept]
   861   C2346484:SENSITIVITY [Phenomenon or Process]
   861   C2349185:Sensitivity [Qualitative Concept]
   789 E C0332324:Sensitive [Functional Concept]
   789 E C1550474:sensitive [Idea or Concept]

Phrase: "was"

Phrase: "circumvented"

Phrase: "when"

Phrase: "one of the antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "amplified"

Phrase: "(Hunyady et al. 1996"

Phrase: ")"

Phrase: "with the catalyzed reporter amplification method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "(CARD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposition [Functional Concept]

Phrase: ")."
Processing 00000000.tx.26: CARD amplification is mediated by the horseradish peroxidase (HRP) on the secondary antibody that catalyzes the activation of tyrosine bound to biotin (Bobrow et al. 1989 ). 

Phrase: "CARD amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "is"

Phrase: "mediated by the horseradish peroxidase (HRP)"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   806   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   760   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0330510:Horseradish [Food]
   760   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   760   C1110641:Horseradish [Plant]
   760   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "on the secondary antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "that"

Phrase: "catalyzes"

Phrase: "the activation of tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1879547:Activation [Activity]

Phrase: "bound to biotin"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   790   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]
   790   C2700256:Biotin [Laboratory Procedure]

Phrase: "(Bobrow et al. 1989"

Phrase: ")."
Processing 00000000.tx.27: The activated tyrosine becomes attached to proteins in the tissue section at the site of the antigenantibody reaction. 

Phrase: "The activated tyrosine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]

Phrase: "becomes"

Phrase: "attached to proteins"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0231441:Attached [Finding]
   756 E C1314972:ATTACH [Intellectual Product]

Phrase: "in the tissue section"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C2316368:Tissue section [Tissue]
   861   C0205155:Section [Spatial Concept]
   861   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   861   C1522472:Section [Substance]
   861   C1552923:Section [Quantitative Concept]
   861   C1705191:Section [Physical Object]

Phrase: "at the site"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205145:Site [Spatial Concept]
  1000   C1515974:Site [Body Location or Region]
  1000   C2825164:Site [Spatial Concept]

Phrase: "of the antigenantibody reaction."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0443286:Reaction [Functional Concept]
   861   C1114821:Reaction [Clinical Attribute]
Processing 00000000.tx.28: Biotin bound to tyrosine can then be visualized (Adams 1992 ). 

Phrase: "Biotin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005575:Biotin [Organic Chemical,Pharmacologic Substance,Vitamin]
  1000   C2700256:Biotin [Laboratory Procedure]

Phrase: "bound to tyrosine"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   790   C0332297:bound [Spatial Concept]
   790   C1145667:Bound [Activity]
   790   C1167622:Bound [Molecular Function]
   790   C1689898:% bound [Quantitative Concept]
   790   C2349209:Bound [Conceptual Entity]

Phrase: "can"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "be"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "(Adams 1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331762:Adams [Health Care Related Organization]

Phrase: ")."
Processing 00000000.tx.29: With this method, discrimination of the two epitopes is possible based on the different sensitivity of the immunodetection systems either with or without the amplification. 

Phrase: "With this method,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "discrimination of the two epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0012632:Discrimination [Mental Process]
   760   C2987623:Discrimination [Social Behavior]

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "based on the different sensitivity of the immunodetection systems either"
Meta Candidates (Total=16; Excluded=3; Pruned=0; Remaining=13)
   739   C0036667:Sensitivity [Quantitative Concept]
   739   C0312418:Sensitivity [Mental Process]
   739   C0427965:Sensitivity [Finding]
   739   C1511883:Sensitivity [Quantitative Concept]
   739   C1522640:Sensitivity [Qualitative Concept]
   739   C1527178:Based [Functional Concept]
   739   C1705242:Different [Qualitative Concept]
   739   C1705938:Based [Idea or Concept]
   739   C2346484:SENSITIVITY [Phenomenon or Process]
   739   C2349185:Sensitivity [Qualitative Concept]
   706 E C0002055:base [Inorganic Chemical]
   706 E C0178499:Base [Chemical Viewed Functionally]
   706   C0449913:System [Functional Concept]
   706   C1553451:System [Manufactured Object]
   706   C1704459:System [Medical Device]
   706 E C1880279:Base [Biomedical or Dental Material]

Phrase: "with"

Phrase: "or without the amplification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.30: The first antibody to be used must be diluted below the level detectable with standard secondary antibody labeled with fluorochrome, but above the level detectable with CARD amplification (Hunyady et al. 1996 ). 

Phrase: "The first antibody to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "be"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "must"

Phrase: "be"

Phrase: "diluted below the level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]
   737   C1720119:Dilute [Functional Concept]
   737   C1948037:Dilute [Functional Concept]

Phrase: "detectable with standard secondary antibody"

Phrase: "labeled with fluorochrome,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]
   790   C1708632:Labeled [Qualitative Concept]
   756 E C0181496:Label [Manufactured Object]
   756 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "but above the level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0441889:Level [Qualitative Concept]
   770   C0456079:Level [Classification]
   770   C1547707:Level [Geographic Area]
   770   C2946261:Level [Pharmacologic Substance]

Phrase: "detectable with CARD amplification"

Phrase: "(Hunyady et al. 1996"

Phrase: ")."
Processing 00000000.tx.31: In the present study we used two different polyclonal antibodies produced in rabbits to visualize two different epitopes possibly co-localizing with each other on the same structure, A40/A42, and A40/von Willebrand factor (a specific marker for vascular endothelial cells). 

Phrase: "In the present study"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0150312:Present [Quantitative Concept]
   861   C0449450:Present [Idea or Concept]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "two different polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   779 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "produced in rabbits to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0034493:Rabbit [Mammal]

Phrase: "visualize"

Phrase: "two different epitopes possibly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003316:Epitopes [Immunologic Factor]

Phrase: "co-localizing with each other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0392752:localizing [Spatial Concept]

Phrase: "on the same structure,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]

Phrase: "A40/A42,"

Phrase: "and"

Phrase: "A40/von Willebrand factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0042971:von Willebrand Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   923   C1336938:VON WILLEBRAND FACTOR [Gene or Genome]
   861   C0042974:von Willebrand [Disease or Syndrome]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]

Phrase: "("

Phrase: "a specific marker for vascular endothelial cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0005516:Marker [Clinical Attribute]

Phrase: ")."
Processing 00000000.tx.32: The third antibody, AT8, a mouse monoclonal antibody (MAb) against paired helical filaments (PHFs), major components of neurofibrillary tangles and neurites (Mercken et al. 1992 ), can be combined by using a differently labeled secondary antibody specific for mouse IgG without danger of crossreaction with these polyclonal antibodies. 

Phrase: "The third antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "AT8,"

Phrase: "a mouse monoclonal antibody (MAb) against paired helical filaments (PHFs),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   800   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0368582:A Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   744   C0746619:monoclonal [Finding]

Phrase: "major components of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0449432:Components [Manufactured Object]
   726 E C1705248:Component [Conceptual Entity]

Phrase: "and"

Phrase: "neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085103:Neurites [Cell Component]

Phrase: "(Mercken et al. 1992"

Phrase: ")"

Phrase: ","

Phrase: "can"

Phrase: "be"

Phrase: "combined by"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   833   C0205195:Combined [Qualitative Concept]
   799 E C0336789:Combine [Manufactured Object]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "a differently"

Phrase: "labeled"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1708632:Labeled [Qualitative Concept]
   966 E C0181496:Label [Manufactured Object]
   966 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "secondary antibody specific for mouse IgG"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   783   C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C2754943:IgG antibody [Cell Component]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0205369:Specific [Qualitative Concept]
   753   C1552740:specific [Intellectual Product]
   718 E C0003264:Antibody Specificity [Molecular Function]

Phrase: "without danger"

Phrase: "of crossreaction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0010357:Cross Reaction [Molecular Function]

Phrase: "with these polyclonal antibodies."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.33: In observing structures, such as senile plaques, that exceed the thickness (510 m) of routine histological sections, we are not sure whether or not portions included in the section under observation represent the entire structure. 

Phrase: "In observing structures,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:structures [Spatial Concept]

Phrase: "such as senile plaques,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   861   C0392079:Senile [Finding]
   827 E C0011389:Plaque [Disease or Syndrome]
   827 E C0332461:Plaque [Finding]
   805 E C0231337:Old age [Finding]
   805 E C1999167:Old age [Population Group]

Phrase: "that"

Phrase: "exceed"

Phrase: "the thickness"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1280412:Thickness [Qualitative Concept]

Phrase: "(510"

Phrase: "m) of routine histological sections,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   760   C0205462:Histological [Functional Concept]
   760   C0205547:Routine [Qualitative Concept]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726   C1705191:Section [Physical Object]

Phrase: "we"

Phrase: "are"

Phrase: "not sure"

Phrase: "whether"

Phrase: "or"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "portions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449719:Portion [Spatial Concept]

Phrase: "included in the section"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   770   C0205155:Section [Spatial Concept]
   770   C0332257:included [Functional Concept]
   770   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   770   C1522472:Section [Substance]
   770   C1552923:Section [Quantitative Concept]
   770   C1705191:Section [Physical Object]
   770   C3538986:INCLUDED [Gene or Genome]
   737 E C1552866:include [Idea or Concept]
   737 E C2700399:Include [Activity]

Phrase: "under observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the entire structure."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0678594:Structure [Spatial Concept]
Processing 00000000.tx.34: We therefore obtained serial optical sections under a laser scanning confocal microscope to be reconstructed for 3D observation. 

Phrase: "We therefore"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "serial optical sections under a laser scanning confocal microscope to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   706   C0205155:Section [Spatial Concept]
   706   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   706   C1522472:Section [Substance]
   706   C1552923:Section [Quantitative Concept]
   706   C1705191:Section [Physical Object]

Phrase: "be"

Phrase: "reconstructed for 3D observation."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0302523:Observation [Research Activity]
   770   C0450363:3D [Spatial Concept]
   770   C0700325:observation [Health Care Activity]
   770   C1964257:Observation [Diagnostic Procedure]
   770   C2348043:Reconstructed [Qualitative Concept]
   770   C2986797:3D [Functional Concept]
Processing 00000000.tx.35: Three-dimensional reconstruction of triple-labeled sections, as we established in this study, can provide an opportunity to observe the entire structure of CWPs and the spatial relationship between the relevant structures. 

Phrase: "Three-dimensional reconstruction of triple-labeled sections,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   814   C0729707:Three-dimensional reconstruction [Diagnostic Procedure]
   748   C0020912:Reconstruction [Machine Activity]
   748   C0524865:Reconstruction [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "we"

Phrase: "established in this study,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0443211:Established [Qualitative Concept]
   770   C0557651:Study [Manufactured Object]
   770   C1272684:Established [Qualitative Concept]
   770   C2603343:Study [Research Activity]

Phrase: "can"

Phrase: "provide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provide [Activity]

Phrase: "an opportunity to"

Phrase: "observe"

Phrase: "the entire structure of CWPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "the spatial relationship between the relevant structures."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]
   732   C0923800:Structural relationship [Conceptual Entity]
Processing 00000000.tx.36: Materials and Methods Top Summary Introduction Materials and Methods Results Discussion Literature Cited A dementia patient with a familial background of Alzheimer disease was diagnosed with AD based on the presence of many senile plaques and neurofibrillary tangles. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "A dementia patient with a familial background of Alzheimer disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0030705:*^patient [Patient or Disabled Group]

Phrase: "was"

Phrase: "diagnosed with AD"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   833   C0002395:Alzheimer's Disease [Disease or Syndrome]
   833   C1521724:Alzheimer's Disease [Pathologic Function]
   770   C0011900:Diagnosed [Finding]
   770   C0012634:Disease [Disease or Syndrome]
   715 E C1836721:MALS [Finding]
   715 E C3538764:MALS [Gene or Genome]
   715 E C3540595:MAL [Gene or Genome]

Phrase: "based on the presence of many senile plaques"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   770   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   744   C0392079:Senile [Finding]
   744   C0392148:Presence [Therapeutic or Preventive Procedure]
   744   C1527178:Based [Functional Concept]
   744   C1705938:Based [Idea or Concept]
   711 E C0002055:base [Inorganic Chemical]
   711 E C0011389:Plaque [Disease or Syndrome]
   711 E C0178499:Base [Chemical Viewed Functionally]
   711 E C0332461:Plaque [Finding]
   711 E C1880279:Base [Biomedical or Dental Material]

Phrase: "and"

Phrase: "neurofibrillary tangles."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.37: Senile plaques in this case were not clearly detectable with the Bodian method, but hematoxylin and eosin staining visualized the cotton wool feature of the plaques without a core. 

Phrase: "Senile plaques in this case"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   760   C0392079:Senile [Finding]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
   704 E C0231337:Old age [Finding]
   704 E C1999167:Old age [Population Group]

Phrase: "were"

Phrase: "not clearly detectable with the Bodian method,"

Phrase: "but"

Phrase: "hematoxylin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0018964:Haematoxylin [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "and"

Phrase: "eosin staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0487602:Staining [Laboratory Procedure]
   861   C1704680:Staining [Finding]

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "the cotton wool feature of the plaques"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1521970:Feature [Qualitative Concept]
   748   C1706388:Feature [Conceptual Entity]
   748   C2346469:Feature [Qualitative Concept]
   748   C2348519:Feature [Qualitative Concept]

Phrase: "without a core."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]
Processing 00000000.tx.38: In addition, a core-like structure and perivascular deposits of A were observed (Nakayama et al. 2001 ; Tabira et al. 2002 ). 

Phrase: "In addition,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "a core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]

Phrase: "like structure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:Structure [Spatial Concept]

Phrase: "and"

Phrase: "perivascular deposits of A"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposits [Functional Concept]

Phrase: "were"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "(Nakayama et al. 2001"

Phrase: "; Tabira et al. 2002"

Phrase: ")."
Processing 00000000.tx.39: The genetic abnormality associated with this phenotype remains to be clarified. 

Phrase: "The genetic abnormality"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
  1000   C0262496:Genetic Abnormality [Finding]
  1000   C1704257:Genetic Abnormality [Finding]
   958 E C0744356:GENITAL ABNORMALITY [Finding]
   861   C1704258:Abnormality [Finding]
   789 E C0205161:Abnormal [Qualitative Concept]
   789 E C2347472:% Abnormal [Quantitative Concept]
   789 E C2699333:ABNORMAL [Intellectual Product]

Phrase: "associated with this phenotype"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0031437:Phenotype [Organism Attribute]
   770   C1285572:Phenotype [Laboratory Procedure]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "remains"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "clarified."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarified [Activity]
Processing 00000000.tx.40: We first undertook experiments to establish the optimal concentrations of the antibodies for the methods used, especially the dilution of the primary antibodies visualized with the CARD method but undetectable by the standard method without CARD amplification. 

Phrase: "We first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "undertook"

Phrase: "experiments to"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "establish"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443211:establish [Qualitative Concept]

Phrase: "the optimal concentrations of the antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0086045:Concentrations [Mental Process]
   719 E C1446561:Concentration [Quantitative Concept]

Phrase: "for the methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "especially"

Phrase: "the dilution of the primary antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1948037:Dilution [Functional Concept]

Phrase: "visualized with the CARD method"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0025663:Method [Intellectual Product]
   748   C0234621:Visualized [Functional Concept]
   748   C0333562:Deposition [Functional Concept]
   748   C0335038:Reporter [Professional or Occupational Group]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]
   748   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   748   C1705915:Reporter [Conceptual Entity]
   748   C1709908:Reporter [Group]

Phrase: "but"

Phrase: "undetectable by the standard method"

Phrase: "without CARD amplification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.41: The list of primary antibodies is provided in Table 1. 

Phrase: "The list of primary antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0745732:List [Conceptual Entity]
   760   C3272378:LIST [Intellectual Product]

Phrase: "is"

Phrase: "provided in Table 1."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
   770   C1999230:Provided [Activity]
Processing 00000000.tx.42: Three-m-thick mirror sections were obtained from formalin-fixed, paraffin-embedded blocks from the occipital lobe of this patient. 

Phrase: "Three-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205449:Three [Quantitative Concept]

Phrase: "m-"

Phrase: "thick mirror sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "obtained from formalin-fixed, paraffin-embedded blocks"
Meta Candidates (Total=15; Excluded=3; Pruned=0; Remaining=12)
   774   C0085185:embedded paraffin [Laboratory Procedure]
   757   C1533157:Fixed Block [Substance]
           Blocks
   748   C0028778:blocks [Pathologic Function]
   748   C0030415:Paraffin [Biomedical or Dental Material,Lipid]
   748   C0231441:Fixed [Finding]
   748   C0332206:Blocks [Functional Concept]
   748   C0443218:Fixed [Qualitative Concept]
   748   C0949307:Formalin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]
   748   C1301820:Obtained [Functional Concept]
   748   C1707903:Embedded [Laboratory Procedure]
   748   C2827483:Fixed [Body Substance]
   714 E C1706084:Block [Geographic Area]
   714 E C1706701:Obtain [Activity]
   714 E C2828370:Block [Quantitative Concept]

Phrase: "from the occipital lobe"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
  1000   C0028785:Occipital lobe [Body Part, Organ, or Organ Component]
  1000   C1268980:Occipital lobe [Body Part, Organ, or Organ Component]
   861   C0796494:lobe [Body Part, Organ, or Organ Component]
   861   C1184145:Occipital [Body Location or Region]
   861   C1428707:Lobe [Gene or Genome]
   861   C3539671:Lobe [Gene or Genome]
   789 E C1522010:Lobar [Qualitative Concept]

Phrase: "of this patient."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:*^patient [Patient or Disabled Group]
Processing 00000000.tx.43: Deparaffinized sections were treated with formic acid (>99%) for 5 min to enhance A-like immunoreactivity (Kitamoto et al. 1987 ). 

Phrase: "Deparaffinized sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "treated with formic acid"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   833   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   833   C0885348:formic acid [Organic Chemical]
   770   C0001128:Acid [Chemical]
   770   C0202406:Acid [Laboratory Procedure]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "("

Phrase: ">99%"

Phrase: ")"

Phrase: "for 5 min to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0702093:/min [Temporal Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "A-like immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "(Kitamoto et al. 1987"

Phrase: ")."
Processing 00000000.tx.44: After being treated with 2% H2O2 and incubation with 5% bovine serum albumin in PBS, sections were incubated at 4C for 2 days with different concentrations (1:10001:100,000) of anti-A40 or anti-A42 antibody (Akiyama et al. 1997 ). 

Phrase: "After"

Phrase: "being"

Phrase: "treated with 2% H2O2"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   770   C0020281:H2O2 [Inorganic Chemical,Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   770   C1522326:Treated [Functional Concept]
   737 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "incubation with 5% bovine serum albumin"

Phrase: "in PBS,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1720830:PBS [Disease or Syndrome]
  1000   C1823521:PBS [Gene or Genome]

Phrase: "sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "incubated at 4C"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0450376:4c [Intellectual Product]
   790   C1439852:Incubated [Laboratory Procedure]

Phrase: "for 2 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "with different concentrations"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0086045:Concentrations [Mental Process]
   827 E C1446561:Concentration [Quantitative Concept]
   777 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10001"

Phrase: ":"

Phrase: "100,000"

Phrase: ")"

Phrase: "of anti-A40"

Phrase: "or"

Phrase: "anti-A42 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(Akiyama et al. 1997"

Phrase: ")."
Processing 00000000.tx.45: One of the mirror sections was visualized after amplification with CARD as previously described (Bobrow et al. 1989 ; Adams 1992 ; Uchihara et al. 2000 ). 

Phrase: "One of the mirror sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "visualized after amplification"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0234621:Visualized [Functional Concept]
   790   C1517480:Amplification [Molecular Biology Research Technique]
   790   C1521871:Amplification [Phenomenon or Process]
   790   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "with CARD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposition [Functional Concept]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Bobrow et al. 1989"

Phrase: "; Adams 1992"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0331762:Adams [Health Care Related Organization]

Phrase: "; Uchihara et al. 2000"

Phrase: ")."
Processing 00000000.tx.46: Briefly, after application of an anti-rabbit IgG made in goat conjugated to horseradish peroxidase (HRP, 1:500; 

Phrase: "Briefly,"

Phrase: "after"

Phrase: "application of an anti-rabbit IgG"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "made in goat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0018019:goat [Mammal]
   790   C1265549:goat [Mammal]
   790   C1510458:Goat [Mammal]
   756   C1881534:Make [Functional Concept]

Phrase: "conjugated to horseradish peroxidase"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   833   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   770   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0330510:Horseradish [Food]
   770   C0522529:Conjugated [Spatial Concept]
   770   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   770   C1110641:Horseradish [Plant]
   770   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(HRP,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0330510:Horseradish [Food]
   861   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   861   C1110641:Horseradish [Plant]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500"

Phrase: ";"
Processing 00000000.tx.47: Pierce, Rockford, IL), the HRP signal was amplified with biotinylated tyramide (1:1000; 

Phrase: "Pierce,"

Phrase: "Rockford,"

Phrase: "IL"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0020898:IL [Geographic Area]
  1000   C0021764:IL [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0022271:IL [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "the HRP signal"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1710082:Signal [Phenomenon or Process]
   734   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]

Phrase: "was"

Phrase: "amplified with biotinylated tyramide"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0673361:biotinylated tyramide [Organic Chemical]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.48: PerkinElmer, Boston, MA) and was finally visualized with FITC conjugated to streptavidin (1:200; 

Phrase: "PerkinElmer,"

Phrase: "Boston,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0006037:Boston [Geographic Area]

Phrase: "MA)"

Phrase: "and"

Phrase: "was"

Phrase: "finally"

Phrase: "visualized with FITC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0234621:Visualized [Functional Concept]

Phrase: "conjugated to streptavidin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   790   C0522529:Conjugated [Spatial Concept]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.49: Vector, Burlingame, CA; 

Phrase: "Vector,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: "Burlingame,"

Phrase: "CA"

Phrase: ";"
Processing 00000000.tx.50: Uchihara et al. 

Phrase: "Uchihara et al."
Processing 00000000.tx.51: 2000 ). 

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.52: The counterpart of the mirror section was visualized with anti-rabbit IgG made in goat conjugated with FITC (1:200; 

Phrase: "The counterpart of the mirror section"

Phrase: "was"

Phrase: "visualized with anti-rabbit IgG"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0034493:Rabbit [Mammal]
   760   C0234621:Visualized [Functional Concept]

Phrase: "made in goat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0018019:goat [Mammal]
   790   C1265549:goat [Mammal]
   790   C1510458:Goat [Mammal]
   756   C1881534:Make [Functional Concept]

Phrase: "conjugated with FITC (1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0522529:Conjugated [Spatial Concept]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.53: Vector).  

Phrase: "Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.54: View this table: [in this window] [in a new window]  Table 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.55: Antibodies and optimal dilutions used in this study For triple immunofluorolabeling, deparaffinized sections were similarly subjected to immunolabeling with CARD amplification with one of the polyclonal antibodies made in rabbits (anti-A42 1:30,000; 

Phrase: "Antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "and"

Phrase: "optimal dilutions"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0079240:dilutions [Laboratory Procedure]
   827 E C1948037:Dilution [Functional Concept]

Phrase: "used in this study"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   802   C0869040:study use [Research Activity]
   770   C0557651:Study [Manufactured Object]
   770   C1273517:used [Finding]
   770   C2603343:Study [Research Activity]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1947944:Use [Intellectual Product]

Phrase: "For triple immunofluorolabeling,"

Phrase: "deparaffinized sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0205155:Section [Spatial Concept]
   827   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   827   C1522472:Section [Substance]
   827   C1552923:Section [Quantitative Concept]
   827   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "similarly"

Phrase: "subjected to immunolabeling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   756   C0681850:Subject [Group]
   756   C1550501:{Subject} [Idea or Concept]
   756   C1706203:Subject [Idea or Concept]
   756   C2349001:Subject [Human]
   756   C2697811:Subject [Functional Concept]

Phrase: "with CARD amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "with one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of the polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "made in rabbits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034493:Rabbit [Mammal]
   756   C1881534:Make [Functional Concept]

Phrase: "(anti-A42 1"

Phrase: ":"

Phrase: "30,000"

Phrase: ";"
Processing 00000000.tx.56: anti-A40 1:30,000; 

Phrase: "anti-A40 1"

Phrase: ":"

Phrase: "30,000"

Phrase: ";"
Processing 00000000.tx.57: or anti-von Willebrand factor 1:1000; 

Phrase: "or"

Phrase: "anti-von Willebrand factor 1"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   884   C0042971:von Willebrand Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   884   C1336938:VON WILLEBRAND FACTOR [Gene or Genome]
   840   C0042974:von Willebrand [Disease or Syndrome]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.58: DAKO, Glostrup, Denmark) as described above and finally visualized to Cy5 conjugated to streptavidin (1:200; 

Phrase: "DAKO,"

Phrase: "Glostrup,"

Phrase: "Denmark"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0011318:Denmark [Geographic Area]

Phrase: ")"

Phrase: "as"

Phrase: "described above"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1552738:described [Idea or Concept]

Phrase: "and"

Phrase: "finally"

Phrase: "visualized to Cy5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0234621:Visualized [Functional Concept]
   790   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "conjugated to streptavidin"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0075278:Streptavidin [Amino Acid, Peptide, or Protein,Biologically Active Substance,Indicator, Reagent, or Diagnostic Aid]
   790   C0522529:Conjugated [Spatial Concept]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.59: Kirkegaard & Perry, Gaithersburg, MD). 

Phrase: "Kirkegaard & Perry,"

Phrase: "Gaithersburg,"

Phrase: "MD)."
Processing 00000000.tx.60: von Willebrand factor is a marker for vascular endothelial cells and the anti-von Willebrand factor antibody immunolabels blood vessels (Uchihara et al. 1995 ). 

Phrase: "von Willebrand factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0042971:von Willebrand Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1336938:VON WILLEBRAND FACTOR [Gene or Genome]
   901   C0042974:von Willebrand [Disease or Syndrome]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "is"

Phrase: "a marker for vascular endothelial cells"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0005516:Marker [Clinical Attribute]

Phrase: "and"

Phrase: "the anti-von Willebrand factor antibody"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   937   C0313543:von Willebrand factor antibody [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   897   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   884   C0042971:von Willebrand Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   884   C1336938:VON WILLEBRAND FACTOR [Gene or Genome]
   840   C0042974:von Willebrand [Disease or Syndrome]
   804   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   804   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]

Phrase: "immunolabels"

Phrase: "blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(Uchihara et al. 1995"

Phrase: ")."
Processing 00000000.tx.61: The sections were then incubated with a mixture of AT8 (1:1000; 

Phrase: "The sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "incubated with a mixture of AT8"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439962:Mixture [Substance]
   753   C1439852:Incubated [Laboratory Procedure]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.62: mouse monoclonal antibody against PHFs; 

Phrase: "mouse monoclonal antibody against PHFs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   814   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   778   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0746619:monoclonal [Finding]

Phrase: ";"
Processing 00000000.tx.63: Innogenetics, Zwijndrecht, Belgium) and another polyclonal antibody (anti-A40 or anti-A42 1:1000) at 4C for another 2 days in the dark. 

Phrase: "Innogenetics,"

Phrase: "Zwijndrecht,"

Phrase: "Belgium"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004950:Belgium [Geographic Area]

Phrase: ")"

Phrase: "and"

Phrase: "another polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "(anti-A40"

Phrase: "or"

Phrase: "anti-A42 1"

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for another 2 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1442455:2 Days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: "in the dark."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332582:Dark [Qualitative Concept]
Processing 00000000.tx.64: These two antibodies were visualized with a mixture of anti-mouse IgG made in sheep conjugated with rhodamine (1:200; 

Phrase: "These two antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "were"

Phrase: "visualized with a mixture of anti-mouse IgG"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   767   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C0432616:Anti A [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0234621:Visualized [Functional Concept]
   744   C0439962:Mixture [Substance]

Phrase: "made in sheep"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0036945:Sheep [Mammal]
   790   C1123019:Sheep [Mammal]
   756   C1881534:Make [Functional Concept]

Phrase: "conjugated with rhodamine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0522529:Conjugated [Spatial Concept]
   790   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.65: Jackson ImmunoResearch, West Grove, PA) and anti-rabbit IgG made in goat conjugated with FITC (1:200; 

Phrase: "Jackson ImmunoResearch,"

Phrase: "West Grove,"

Phrase: "PA)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3541314:PA [Idea or Concept]

Phrase: "and"

Phrase: "anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0034493:Rabbit [Mammal]

Phrase: "made in goat"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0018019:goat [Mammal]
   790   C1265549:goat [Mammal]
   790   C1510458:Goat [Mammal]
   756   C1881534:Make [Functional Concept]

Phrase: "conjugated with FITC (1"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0522529:Conjugated [Spatial Concept]
   737 E C0301869:Conjugate [Immunologic Factor]

Phrase: ":"

Phrase: "200"

Phrase: ";"
Processing 00000000.tx.66: Vector), respectively. 

Phrase: "Vector"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
  1000   C0442335:Vector [Spatial Concept]
  1000   C1705099:Vector [Idea or Concept]

Phrase: ")"

Phrase: ","

Phrase: "respectively."
Processing 00000000.tx.67: For 3D observation, formalin-fixed blocks were washed in PBS and cryoprotected by being soaked in 20% sucrose buffered with 0.1 M phosphate. 

Phrase: "For 3D observation,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0302523:Observation [Research Activity]
   861   C0700325:observation [Health Care Activity]
   861   C1964257:Observation [Diagnostic Procedure]
   789 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "formalin-fixed blocks"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   884   C1533157:Fixed Block [Substance]
           Blocks
   827   C0028778:blocks [Pathologic Function]
   827   C0332206:Blocks [Functional Concept]
   793 E C1706084:Block [Geographic Area]
   793 E C2828370:Block [Quantitative Concept]
   743 E C2983591:BLOCKED [Research Activity]

Phrase: "were"

Phrase: "washed in PBS"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C1548982:Washed [Idea or Concept]
   790   C1720830:PBS [Disease or Syndrome]
   790   C1823521:PBS [Gene or Genome]
   756 E C0441648:Wash [Activity]

Phrase: "and"

Phrase: "cryoprotected by"

Phrase: "being"

Phrase: "soaked in 20% sucrose"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0038636:Sucrose [Biologically Active Substance,Carbohydrate,Pharmacologic Substance]
   770   C0204774:soaked [Therapeutic or Preventive Procedure]
   770   C1161331:sucrose [Carbohydrate,Pharmacologic Substance]
   737 E C1549544:Soak [Functional Concept]

Phrase: "buffered with 0.1 M phosphate."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   783   C0991865:buffered phosphate [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0006353:Buffered [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   753   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   753   C0031701:phosphate [Organophosphorus Compound]
   753   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0441923:M+ [Intellectual Product]
   753   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]
Processing 00000000.tx.68: Thick floating sections (50100-m in thickness) were obtained on a freezing microtome. 

Phrase: "Thick floating sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "(50100-m in thickness"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441923:M+ [Intellectual Product]

Phrase: ")"

Phrase: "were"

Phrase: "obtained on a freezing microtome."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   760   C0016701:Freezing [Natural Phenomenon or Process]
   760   C0181856:microtome [Medical Device]
   760   C0700320:microtome [Laboratory Procedure]
   760   C1301820:Obtained [Functional Concept]
   726 E C1706701:Obtain [Activity]
Processing 00000000.tx.69: They were subjected to the triple-immunolabeling method as above with prolonged incubation (up to 7 days) with the primary antibody. 

Phrase: "They"

Phrase: "were"

Phrase: "subjected to the triple-immunolabeling method"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   753   C0025663:Method [Intellectual Product]
   753   C0205174:Triple [Quantitative Concept]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
   719   C0681850:Subject [Group]
   719   C1550501:{Subject} [Idea or Concept]
   719   C1706203:Subject [Idea or Concept]
   719   C2349001:Subject [Human]
   719   C2697811:Subject [Functional Concept]

Phrase: "as above"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282910:Above [Spatial Concept]
  1000   C1552828:above [Idea or Concept]

Phrase: "with prolonged incubation"

Phrase: "("

Phrase: "up to 7 days"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C1547085:7 days [Temporal Concept]
   861   C0439228:days [Temporal Concept]
   827 E C0332173:/day [Temporal Concept]
   827 E C0439505:/day [Temporal Concept]

Phrase: ")"

Phrase: "with the primary antibody."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.70: Sections were mounted with 90% glycerol in 0.1 M phosphate buffer containing 0.1% of p-phenylenediamine and were observed under a confocal laser scanning microscope (Leica TCS/SP; Heidelberg, Germany). 

Phrase: "Sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   966   C0205155:Section [Spatial Concept]
   966   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   966   C1522472:Section [Substance]
   966   C1552923:Section [Quantitative Concept]
   966   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "mounted with 90% glycerol"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0017861:Glycerol [Biologically Active Substance,Organic Chemical,Pharmacologic Substance]
   770   C0439083:>90 [Quantitative Concept]
   770   C0439087:<90 [Quantitative Concept]
   770   C0449878:mounted [Finding]
   737 E C0181909:Mount [Medical Device]

Phrase: "in 0.1 M phosphate buffer"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   840   C0991865:Phosphate Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0006353:Buffer [Indicator, Reagent, or Diagnostic Aid,Pharmacologic Substance]
   804   C0031603:Phosphate [Inorganic Chemical,Pharmacologic Substance]
   804   C0031701:phosphate [Organophosphorus Compound]
   804   C1601799:PHOSPHATE [Inorganic Chemical,Pharmacologic Substance]

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "0.1% of p-phenylenediamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0031468:PHENYLENEDIAMINE [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "were"

Phrase: "observed under a confocal laser scanning microscope"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   774   C1626420:Confocal microscope [Medical Device]
   748   C0023089:Laser [Manufactured Object]
   748   C0034606:Scanning [Diagnostic Procedure]
   748   C0181839:Microscope [Medical Device]
   748   C0441633:Scanning [Diagnostic Procedure]
   748   C0458142:Laser [Phenomenon or Process]
   748   C1023865:Laser [Plant]
   748   C1441672:Observed [Functional Concept]
   748   C1706315:Laser [Medical Device]
   748   C1706379:Microscope [Medical Device]
   714 E C2826292:SCAN [Finding]

Phrase: "(Leica TCS/SP"

Phrase: "; Heidelberg,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")."
Processing 00000000.tx.71: Excitation of the fluorochromes and their maximal detection wavelength are summarized in Table 2. 

Phrase: "Excitation of the fluorochromes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0549255:Excitation [Activity]

Phrase: "and"

Phrase: "their maximal detection wavelength"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0449819:Wavelength [Quantitative Concept]

Phrase: "are"

Phrase: "summarized in Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0039224:Table [Manufactured Object]
   770   C1706073:Table [Medical Device]
   770   C1706074:Table [Intellectual Product]
Processing 00000000.tx.72: Serial optical sections were obtained and reconstructed for 3D analysis on software (TRI/3D; Ratoc System, Tokyo, Japan).  

Phrase: "Serial optical sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "were"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "and"

Phrase: "reconstructed for 3D analysis"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0450363:3D [Spatial Concept]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C2348043:Reconstructed [Qualitative Concept]
   770   C2986797:3D [Functional Concept]

Phrase: "on software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(TRI/"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0814229:TRI [Intellectual Product]

Phrase: "3D"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0450363:3D [Spatial Concept]
  1000   C2986797:3D [Functional Concept]

Phrase: "; Ratoc System,"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0449913:System [Functional Concept]
   861   C1553451:System [Manufactured Object]
   861   C1704459:System [Medical Device]
   789 E C0205373:Systemic [Functional Concept]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.73: View this table: [in this window] [in a new window]  Table 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 2."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]
Processing 00000000.tx.74: Fluorescent dyes and their link to epitopes Results Top Summary Introduction Materials and Methods Results Discussion Literature Cited Serial dilution of one of the polyclonal antibodies (anti-A40) demonstrated that the usual immunofluorescence method without CARD amplification (Fig 1A, Fig 1C, Fig 1E, and Fig 1G) requires a high concentration of the antibody (1:1000) to obtain maximal labeling (Fig 1C). 

Phrase: "Fluorescent dyes"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016320:Fluorescent Dyes [Indicator, Reagent, or Diagnostic Aid]
   861   C0013343:Dyes [Indicator, Reagent, or Diagnostic Aid]
   861   C2757062:Dyes [Molecular Function]
   861   C2911146:Dyes NOS [Finding]

Phrase: "and"

Phrase: "their link to epitopes Results Top Summary Introduction Materials"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1517892:Link [Intellectual Product]
   742   C1704666:Link [Intellectual Product]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Serial dilution of one of the polyclonal antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0031082:serial [Intellectual Product,Manufactured Object]
   744   C0079240:Dilution [Laboratory Procedure]
   744   C1948037:Dilution [Functional Concept]

Phrase: "(anti-A40"

Phrase: ")"

Phrase: "demonstrated"

Phrase: "that"

Phrase: "the usual immunofluorescence method without CARD amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "(Fig 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "Fig 1C,"

Phrase: "Fig 1E,"

Phrase: "and"

Phrase: "Fig 1G"

Phrase: ")"

Phrase: "requires"

Phrase: "a high concentration of the antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0086045:Concentration [Mental Process]
   753   C1446561:Concentration [Quantitative Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "maximal labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "(Fig 1C"

Phrase: ")."
Processing 00000000.tx.75: However, CARD amplification (Fig 1B, Fig 1D, Fig 1F, and Fig 1H) enabled us to use the antibody at lower concentrations (up to 1:30,000) to obtain a clear fluorescent signal of an equivalent intensity with little background staining (Fig 1F). 

Phrase: "However,"

Phrase: "CARD amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "(Fig 1B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: "Fig 1D, Fig 1F,"

Phrase: "and"

Phrase: "Fig 1H"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1442450:1H [Temporal Concept]

Phrase: ")"

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "use"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0042153:use [Functional Concept]
  1000   C0457083:Use [Functional Concept]
  1000   C1947944:Use [Intellectual Product]

Phrase: "the antibody at lower concentrations"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "("

Phrase: "up to 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "30,000"

Phrase: ")"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "a clear fluorescent signal of an equivalent intensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C0871362:signal intensity [Quantitative Concept]
   744   C1710082:Signal [Phenomenon or Process]

Phrase: "with little background staining"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0487602:Staining [Laboratory Procedure]
   827   C1704680:Staining [Finding]

Phrase: "(Fig 1F"

Phrase: ")."
Processing 00000000.tx.76: Omission of either primary antibody, secondary antibody, or biotinylated tyramide completely eliminated the immunofluorescent signal. 

Phrase: "Omission of either primary antibody,"

Phrase: "secondary antibody,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "or"

Phrase: "biotinylated tyramide completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0673361:biotinylated tyramide [Organic Chemical]

Phrase: "eliminated"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0849355:Eliminated [Qualitative Concept]

Phrase: "the immunofluorescent signal."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.77: Similar results were obtained with the anti-A42 antibody (data not shown). 

Phrase: "Similar results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "were"

Phrase: "obtained with the anti-A42 antibody"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1301820:Obtained [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.78: View larger version (54K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(54K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.79: Immunolabeling of mirror-section pairs from cerebral cortex with anti-A40 at dilution 1:1000 (A,B), 1:10,000 (C,D), 1:30,000 (E,F), and 1:100,000 (G,H) visualized without (A,C,E,G) and with (B,D,F,H) CARD amplification. 

Phrase: "Immunolabeling of mirror-section"

Phrase: "pairs from cerebral cortex"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   770   C1176472:Cortex [Body Part, Organ, or Organ Component]
   770   C1709450:Pair [Qualitative Concept]
   770   C2700441:Cortex [Plant]

Phrase: "with anti-A40"

Phrase: "at dilution 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ":"

Phrase: "1000"

Phrase: "(A,B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1440044:A,B [Immunologic Factor]

Phrase: ")"

Phrase: ","

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "10,000"

Phrase: "(C,D),"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0012358:c d [Therapeutic or Preventive Procedure]
   861   C1553033:[c] [Quantitative Concept]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "30,000"

Phrase: "(E,F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "and"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "100,000"

Phrase: "(G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439267:g% [Quantitative Concept]

Phrase: "H)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0033727:H+ [Element, Ion, or Isotope]
  1000   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441932:H+ [Classification]
  1000   C0564385:/h [Quantitative Concept]

Phrase: "visualized without"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C0234621:Visualized [Functional Concept]

Phrase: "(A,C,"

Phrase: "E,G)"

Phrase: "and with"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   833   C1515981:And [Idea or Concept]

Phrase: "(B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "D,"

Phrase: "F,H) CARD amplification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C1517480:Amplification [Molecular Biology Research Technique]
   799   C1521871:Amplification [Phenomenon or Process]
   799   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.80: At dilution 1:30,000, labeling after CARD amplification visualized A40 deposits (F), but that without the amplification failed to exhibit labeling (E). 

Phrase: "At dilution 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ":"

Phrase: "30,000,"

Phrase: "labeling after CARD amplification"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   753   C0333562:Deposition [Functional Concept]
   753   C0335038:Reporter [Professional or Occupational Group]
   753   C1167624:Labeling [Mental Process]
   753   C1517480:Amplification [Molecular Biology Research Technique]
   753   C1521871:Amplification [Phenomenon or Process]
   753   C1522485:Reporter [Indicator, Reagent, or Diagnostic Aid]
   753   C1705759:Amplification [Cell or Molecular Dysfunction]
   753   C1705915:Reporter [Conceptual Entity]
   753   C1709908:Reporter [Group]
   753   C1947902:Labeling [Manufactured Object]
   753   C2827499:Labeling [Governmental or Regulatory Activity]
   719 E C0181496:Label [Manufactured Object]

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "A40 deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0333562:Deposits [Functional Concept]

Phrase: "(F),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "but"

Phrase: "that without the amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "failed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:Failed [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "labeling"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C1167624:Labeling [Mental Process]
  1000   C1947902:Labeling [Manufactured Object]
  1000   C2827499:Labeling [Governmental or Regulatory Activity]
   966 E C0181496:Label [Manufactured Object]

Phrase: "(E"

Phrase: ")."
Processing 00000000.tx.81: Bar = 100 m. 

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.82: Therefore, we first performed CARD-amplified immunofluorolabeling with anti-A40 (Fig 2A2C), which was visualized with Cy5, shown as blue. 

Phrase: "Therefore,"

Phrase: "we first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "CARD-amplified immunofluorolabeling with anti-A40"

Phrase: "(Fig 2A2C"

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "was"

Phrase: "visualized with Cy5,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0234621:Visualized [Functional Concept]
   790   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "shown as blue."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1260957:Blue [Qualitative Concept]
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.83: Subsequent double labeling with AT8 (1:1000; 

Phrase: "Subsequent double labeling with AT8"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0205173:Double [Functional Concept]
   760   C1167624:Labeling [Mental Process]
   760   C1705764:Double [Activity]
   760   C1705765:Double [Qualitative Concept]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]
   726 E C0181496:Label [Manufactured Object]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.84: Fig 2A2C, red) and with anti-A42 (1:1000; 

Phrase: "Fig 2A2C,"

Phrase: "red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and with anti-A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1515981:And [Idea or Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000"

Phrase: ";"
Processing 00000000.tx.85: Fig 2A and Fig 2C, green) antibody was visualized with the mixture of anti-mouse IgG conjugated with rhodamine and anti-rabbit IgG conjugated with FITC. 

Phrase: "Fig 2A"

Phrase: "and"

Phrase: "Fig 2C,"

Phrase: "green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "visualized with the mixture of anti-mouse IgG"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0025914:Mouse [Mammal]
   744   C0025929:mouse [Mammal]
   744   C0026809:Mouse [Mammal]
   744   C0234621:Visualized [Functional Concept]
   744   C0439962:Mixture [Substance]

Phrase: "conjugated with rhodamine"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0522529:Conjugated [Spatial Concept]
   790   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   756 E C0301869:Conjugate [Immunologic Factor]

Phrase: "and"

Phrase: "anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   913   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0034493:Rabbit [Mammal]

Phrase: "conjugated with FITC."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C0522529:Conjugated [Spatial Concept]
   756 E C0301869:Conjugate [Immunologic Factor]
Processing 00000000.tx.86: As shown in Fig 2, no crossreaction between the two rabbit polyclonal antibodies (anti-A40 and anti-A42) was detectable. 

Phrase: "As"

Phrase: "shown in Fig 2,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]

Phrase: "no crossreaction between the two rabbit polyclonal antibodies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0010357:Cross Reaction [Molecular Function]

Phrase: "(anti-A40"

Phrase: "and"

Phrase: "anti-A42"

Phrase: ")"

Phrase: "was"

Phrase: "detectable."
Processing 00000000.tx.87: Moreover, it is noteworthy that reverse experiments, anti-A42 with amplification followed by anti-A40, gave essentially the same results (Fig 3). 

Phrase: "Moreover,"

Phrase: "it"

Phrase: "is"

Phrase: "noteworthy"

Phrase: "that reverse experiments,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "anti-A42 with amplification"

Phrase: "followed by anti-A40,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   833   C0332283:Followed by [Temporal Concept]
           followed
   737 E C1719822:Follow [Intellectual Product]

Phrase: "gave"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1947971:Give [Functional Concept]

Phrase: "essentially"

Phrase: "the same results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1274040:Result [Functional Concept]
   827   C1546471:Result [Idea or Concept]
   827   C2825142:Result [Finding]

Phrase: "(Fig 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.88: View larger version (114K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(114K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.89: (A) Cerebral cortex (pial surface, right upper corner; white matter, left lower corner) immunofluorolabeled with anti-A42 (green), anti-A40 (blue), and anti-PHF (red). 

Phrase: "(A) Cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]

Phrase: "(pial surface,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205148:Surface [Spatial Concept]

Phrase: "right upper corner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1879655:Corner - [Laboratory Procedure]
   827   C1879656:Corner + [Laboratory Procedure]

Phrase: "; white matter,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0682708:White matter [Tissue]
   861   C0007457:White [Population Group]
   861   C0043157:White [Population Group]
   861   C0220938:White [Qualitative Concept]

Phrase: "left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205091:Left [Spatial Concept]
  1000   C1552822:left [Functional Concept]

Phrase: "lower corner"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1879655:Corner - [Laboratory Procedure]
   861   C1879656:Corner + [Laboratory Procedure]

Phrase: ")"

Phrase: "immunofluorolabeled with anti-A42"

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-A40"

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti-PHF (red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332575:Red [Finding]
   827   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.90: Large deposits of A42 are scattered without specific laminar distribution. 

Phrase: "Large deposits of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "scattered without specific laminar distribution."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205274:Laminar [Spatial Concept]
   760   C0205369:Specific [Qualitative Concept]
   760   C0439742:Scattered [Spatial Concept]
   760   C0520511:distribution [Idea or Concept]
   760   C1552740:specific [Intellectual Product]
   760   C1704711:Distribution [Functional Concept]
Processing 00000000.tx.91: (B) The same field as A. 

Phrase: "(B)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: "The same field as A."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   760   C1521738:Field [Conceptual Entity]
   760   C2346620:Field [Conceptual Entity]
   760   C2349184:Field [Conceptual Entity]
   760   C3539073:FIELD [Spatial Concept]
Processing 00000000.tx.92: Immunolabeling with anti-A42 is deleted from A. 

Phrase: "Immunolabeling with anti-A42"

Phrase: "is"

Phrase: "deleted from A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1880274:Deleted [Activity]
Processing 00000000.tx.93: Laminar distribution of neurofibrillary tangles is evident. 

Phrase: "Laminar distribution of neurofibrillary tangles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0520511:distribution [Idea or Concept]
   760   C1704711:Distribution [Functional Concept]

Phrase: "is"

Phrase: "evident."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   928   C0332120:Evidence [Functional Concept]
Processing 00000000.tx.94: Deposits of A40 are rare in the deep layers (asterisk), where deposits of A42 are numerous (A). 

Phrase: "Deposits of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333562:Deposits [Functional Concept]

Phrase: "are"

Phrase: "rare in the deep layers"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0521114:Rare [Temporal Concept]
   760   C0522498:Rare [Qualitative Concept]
   760   C1514917:RARE [Gene or Genome]

Phrase: "(asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: ")"

Phrase: ","

Phrase: "where"

Phrase: "deposits of A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0333562:Deposit [Functional Concept]

Phrase: "are"

Phrase: "numerous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439064:Numerous [Quantitative Concept]

Phrase: "(A"

Phrase: ")."
Processing 00000000.tx.95: Bars = 500 m. 

Phrase: "Bars"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C1707156:BARS [Gene or Genome]
  1000   C3274014:BARS [Intellectual Product]
  1000   C3541345:BARS [Intellectual Product]
   966 E C0687760:bar [Manufactured Object]
   966 E C1551065:bar [Quantitative Concept]

Phrase: "= 500 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.96: (C) Higher magnification of A. 

Phrase: "(C) Higher magnification of A."
Processing 00000000.tx.97: Core-like structures (arrowheads) are positive for both A40 and A42, whereas large cotton wool plaques are mainly positive for A42 (arrows). 

Phrase: "Core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "are"

Phrase: "positive for both A40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "A42,"

Phrase: "whereas"

Phrase: "large cotton wool plaques"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0333463:plaques [Acquired Abnormality]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]

Phrase: "are"

Phrase: "mainly positive for A42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.98: Bar = 250 m. 

Phrase: "Bar = 250 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.99: Figure 3. 

Phrase: "Figure 3."
Processing 00000000.tx.100: Triple immunofluorolabeling of the cerebral cortex with anti-A42 (blue), anti-A40 (green), and anti-PHF tau (red). 

Phrase: "Triple immunofluorolabeling of the cerebral cortex"

Phrase: "with anti-A42"

Phrase: "(blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "anti-A40"

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "anti-PHF tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
   827   C1720655:Tau [Intellectual Product]
   827   C1947974:Tau [Research Activity]

Phrase: "(red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.101: Cotton wool plaques (asterisks) are positive mainly for A42, and participation of A40 is not detectable. 

Phrase: "Cotton wool plaques"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   734   C0440207:Cotton wool [Biomedical or Dental Material]

Phrase: "(asterisks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisks [Conceptual Entity]

Phrase: ")"

Phrase: "are"

Phrase: "positive mainly for A42,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C2825490:Positive [Qualitative Concept]

Phrase: "and"

Phrase: "participation of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0679823:Participation [Functional Concept]

Phrase: "is"

Phrase: "not detectable."
Processing 00000000.tx.102: Core-like structures (arrowheads) and blood vessel (arrow) are positive for A40 and for A42 to a lesser extent. 

Phrase: "Core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "(arrowheads"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1080898:Arrowheads [Plant]
   966 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "and"

Phrase: "blood vessel"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
  1000   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
  1000   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   944 E C1558950:VASCULAR [Finding]
   944 E C1801960:Vascular [Qualitative Concept]
   916 E C0005767:Blood [Tissue]
   916 E C0005768:blood [Body Substance]
   916 E C0229664:Blood [Body Substance]
   916 E C0392895:Bloods [Population Group]
   893 E C0333275:Bloody [Qualitative Concept]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(arrow"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:Arrow [Manufactured Object]

Phrase: ")"

Phrase: "are"

Phrase: "positive for A40"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0439178:% Positive [Quantitative Concept]
   790   C1446409:Positive [Qualitative Concept]
   790   C1514241:Positive [Finding]
   790   C2825490:Positive [Qualitative Concept]

Phrase: "and for A42"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1515981:And [Idea or Concept]

Phrase: "to a lesser extent."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439792:Extent [Spatial Concept]
Processing 00000000.tx.103: Reactive neurites are slender and are clustered around CWPs but are not detectable around A40-positive structures. 

Phrase: "Reactive neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0085103:Neurites [Cell Component]

Phrase: "are"

Phrase: "slender"

Phrase: "and"

Phrase: "are"

Phrase: "clustered around CWPs"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   806   C0440207:Cotton wool [Biomedical or Dental Material]
   760   C0010196:Cotton [Plant]
   760   C0043220:Wool [Substance]
   760   C0330523:cotton [Plant]
   760   C0330524:cotton [Plant]
   760   C0333463:plaques [Acquired Abnormality]
   760   C1095832:Cotton [Substance]
   760   C1561494:Wool [Intellectual Product]
   726 E C0011389:Plaque [Disease or Syndrome]
   726 E C0332461:Plaque [Finding]
   726   C1555715:Cluster [Idea or Concept]
   726   C1704332:Cluster [Quantitative Concept]

Phrase: "but"

Phrase: "are"

Phrase: "not detectable around A40-positive structures."
Processing 00000000.tx.104: Bar = 100 m. 

Phrase: "Bar = 100 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.105: Figure 4. 

Phrase: "Figure 4."
Processing 00000000.tx.106: A total of 114 optical sections (XY with the interval of 0.3 m along Z-axis) were obtained from a triple-labeled thick floating section (green, A40; red, PHF-tau; blue, von Willebrand factor for blood vessels) from the cerebral cortex. 

Phrase: "A total of 114 optical sections"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0439175:% total [Quantitative Concept]
   753   C0439810:Total [Qualitative Concept]

Phrase: "(XY with the interval of 0.3 m"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710693:XY [Organism Attribute]

Phrase: "along Z-axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "obtained from a triple-labeled thick floating section"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   744   C0205155:Section [Spatial Concept]
   744   C0205174:Triple [Quantitative Concept]
   744   C1280412:Thick [Qualitative Concept]
   744   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   744   C1301820:Obtained [Functional Concept]
   744   C1522472:Section [Substance]
   744   C1552923:Section [Quantitative Concept]
   744   C1705191:Section [Physical Object]
   744   C1708632:Labeled [Qualitative Concept]
   711 E C0181496:Label [Manufactured Object]
   711 E C1706701:Obtain [Activity]
   711   C1708071:Float [Qualitative Concept]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "A40"

Phrase: "; red,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "PHF-tau"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "; blue,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: "von Willebrand factor for blood vessels"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0042971:von Willebrand Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   833   C1336938:VON WILLEBRAND FACTOR [Gene or Genome]
   790   C0042974:von Willebrand [Disease or Syndrome]
   785   C0078057:vascular factor [Amino Acid, Peptide, or Protein]
   753   C1521761:Factor [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]

Phrase: ")"

Phrase: "from the cerebral cortex."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]
Processing 00000000.tx.107: Three-dimensional reconstruction was performed on the software. 

Phrase: "Three-dimensional reconstruction"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0729707:Three-dimensional reconstruction [Diagnostic Procedure]
   827   C0020912:Reconstruction [Machine Activity]
   827   C0524865:Reconstruction [Therapeutic or Preventive Procedure]
   734   C0450363:3-Dimensional [Spatial Concept]

Phrase: "was"

Phrase: "performed on the software."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0037585:Software [Intellectual Product,Manufactured Object]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.108: (A) Stacked image of the 114 optical sections (XY). 

Phrase: "(A) Stacked image of the 114 optical sections"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1704254:Image [Intellectual Product]
   744   C1704922:Image [Entity]
   744   C3542466:Image [Intellectual Product]

Phrase: "(XY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710693:XY [Organism Attribute]

Phrase: ")."
Processing 00000000.tx.109: Core-like structures (A40) were clustered along the blood vessel. 

Phrase: "Core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "(A40"

Phrase: ")"

Phrase: "were"

Phrase: "clustered along the blood vessel."
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   806   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   806   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   806   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   751 E C1558950:VASCULAR [Finding]
   751 E C1801960:Vascular [Qualitative Concept]
   726   C1555715:Cluster [Idea or Concept]
   726   C1704332:Cluster [Quantitative Concept]
   723 E C0005767:Blood [Tissue]
   723 E C0005768:blood [Body Substance]
   723 E C0229664:Blood [Body Substance]
   723 E C0392895:Bloods [Population Group]
   704 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
   700 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.110: (B) One of the optical sections (XY) at the depth indicated with white lines in C and D. 

Phrase: "(B) One of the optical sections"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0205447:One [Quantitative Concept]

Phrase: "(XY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1710693:XY [Organism Attribute]

Phrase: ")"

Phrase: "at the depth"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0205125:Depth [Spatial Concept]
   928 E C1422002:DEEPEST [Gene or Genome]

Phrase: "indicated with white lines"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0007457:White [Population Group]
   770   C0043157:White [Population Group]
   770   C0205132:lines [Spatial Concept]
   770   C0220938:White [Qualitative Concept]
   770   C1444656:Indicated [Finding]
   737 E C1550648:Line [Substance]
   737 E C1552960:Line [Quantitative Concept]

Phrase: "in C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.111: (C) Cross-sectional YZ image along the yellow lines indicated in B and D. 

Phrase: "(C) Cross-sectional YZ image along the yellow lines"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C1704254:Image [Intellectual Product]
   742   C1704922:Image [Entity]
   742   C3542466:Image [Intellectual Product]

Phrase: "indicated in B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "D."
Processing 00000000.tx.112: (D) Cross-sectional XZ image along the red line indicated in B and C. 

Phrase: "("

Phrase: "D)"

Phrase: "Cross-sectional XZ image along the red line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1704254:Image [Intellectual Product]
   744   C1704922:Image [Entity]
   744   C3542466:Image [Intellectual Product]

Phrase: "indicated in B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1444656:Indicated [Finding]

Phrase: "and"

Phrase: "C."
Processing 00000000.tx.113: (E) Cross-sectional image along the blood vessel indicated with a white arbitrary line in A with two extremities marked as arrowhead and asterisk. 

Phrase: "(E) Cross-sectional image along the blood vessel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1704254:Image [Intellectual Product]
   744   C1704922:Image [Entity]
   744   C3542466:Image [Intellectual Product]

Phrase: "indicated with a white arbitrary line"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   753   C0007457:White [Population Group]
   753   C0043157:White [Population Group]
   753   C0205132:Line [Spatial Concept]
   753   C0220938:White [Qualitative Concept]
   753   C1264693:*Arbitrary [Quantitative Concept]
   753   C1444656:Indicated [Finding]
   753   C1550648:Line [Substance]
   753   C1552960:Line [Quantitative Concept]

Phrase: "in A with two extremities"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0015385:Extremities [Body Part, Organ, or Organ Component]
   827   C0278454:extremities [Body Part, Organ, or Organ Component]
   755 E C0439746:Acral [Spatial Concept]
   743 E C0205403:Extreme [Qualitative Concept]
   734 E C1522410:Apex [Qualitative Concept]

Phrase: "marked as arrowhead"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0453107:Arrowhead [Food]
   790   C0522501:Marked [Qualitative Concept]
   790   C1080898:Arrowhead [Plant]
   790   C1706089:Marked [Qualitative Concept]

Phrase: "and"

Phrase: "asterisk."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]
Processing 00000000.tx.114: Focal deposition of A40 in the vessel wall was occasionally in continuity with core-like structures around the vessel wall. 

Phrase: "Focal deposition of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0333562:Deposition [Functional Concept]

Phrase: "in the vessel wall"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C0677535:Wall [Manufactured Object]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "occasionally in continuity with core-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0595960:Continuity [Qualitative Concept]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "around the vessel wall."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C0677535:Wall [Manufactured Object]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.115: Bar = 50 m. 

Phrase: "Bar = 50 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.116: Most of the CWPs were homogeneously labeled with the anti-A42 antibody [green in Fig 2 (arrows) and blue in Fig 3], and participation of A40 was partial on these CWPs (blue in Fig 2 and green in Fig 3). 

Phrase: "Most of the CWPs"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   790   C0440207:Cotton wool [Biomedical or Dental Material]
   753   C0010196:Cotton [Plant]
   753   C0043220:Wool [Substance]
   753   C0205393:Most [Quantitative Concept]
   753   C0330523:cotton [Plant]
   753   C0330524:cotton [Plant]
   753   C0333463:plaques [Acquired Abnormality]
   753   C1095832:Cotton [Substance]
   753   C1561494:Wool [Intellectual Product]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "homogeneously"

Phrase: "labeled with the anti-A42 antibody"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "[green in Fig 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332583:Green [Qualitative Concept]

Phrase: "(arrows"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0336721:arrows [Manufactured Object]

Phrase: ")"

Phrase: "and"

Phrase: "blue in Fig 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1260957:Blue [Qualitative Concept]

Phrase: "],"

Phrase: "and"

Phrase: "participation of A40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0679823:Participation [Functional Concept]

Phrase: "was"

Phrase: "partial on these CWPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0728938:Partial [Quantitative Concept]
   753   C1550516:partial [Idea or Concept]

Phrase: "(blue in Fig 2"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1260957:Blue [Qualitative Concept]

Phrase: "and"

Phrase: "green in Fig 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   819   C0060087:Green 3 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.117: In contrast, A40 was deposited as core-like structures (arrowheads in Fig 2C and Fig 3), which were rare in deeper layers of the cerebral cortices (asterisk in Fig 2B, blue) and contained also A42 (arrowheads in Fig 2C). 

Phrase: "In contrast,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1979874:Contrast [Qualitative Concept]

Phrase: "A40"

Phrase: "was"

Phrase: "deposited as core-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0333562:deposited [Functional Concept]
   790   C0444669:Core [Spatial Concept]
   790   C1167518:core [Cell Component]
   790   C1706352:Core [Medical Device]
   790   C1882467:Core [Manufactured Object]
   790   C3274653:Core [Body Substance]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "(arrowheads in Fig 2C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1080898:Arrowheads [Plant]
   737 E C0453107:Arrowhead [Food]

Phrase: "and"

Phrase: "Fig 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "were"

Phrase: "rare in deeper layers of the cerebral cortices"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C0521114:Rare [Temporal Concept]
   744   C0522498:Rare [Qualitative Concept]
   744   C1514917:RARE [Gene or Genome]

Phrase: "(asterisk in Fig 2B,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2945706:asterisk [Conceptual Entity]

Phrase: "blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "contained"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:contained [Functional Concept]
  1000   C2700400:Contained [Activity]

Phrase: "also A42"

Phrase: "(arrowheads in Fig 2C"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1080898:Arrowheads [Plant]
   737 E C0453107:Arrowhead [Food]

Phrase: ")."
Processing 00000000.tx.118: Three-dimensional analysis demonstrated that these core-like structures positive for A40 (Fig 4, green) were sometimes clustered along the blood vessel (arrowhead in Fig 4A). 

Phrase: "Three-dimensional analysis"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0002778:Analysis [Laboratory Procedure]
   827   C0936012:Analysis [Research Activity]
   827   C1524024:analysis [Functional Concept]
   734   C0450363:3-Dimensional [Spatial Concept]

Phrase: "demonstrated"

Phrase: "that"

Phrase: "these core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]

Phrase: "like structures positive"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0439178:% Positive [Quantitative Concept]
   861   C1446409:Positive [Qualitative Concept]
   861   C1514241:Positive [Finding]
   861   C2825490:Positive [Qualitative Concept]

Phrase: "for A40"

Phrase: "(Fig 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "were"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "clustered along the blood vessel"
Meta Candidates (Total=15; Excluded=8; Pruned=0; Remaining=7)
   806   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   806   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   806   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   751 E C1558950:VASCULAR [Finding]
   751 E C1801960:Vascular [Qualitative Concept]
   726   C1555715:Cluster [Idea or Concept]
   726   C1704332:Cluster [Quantitative Concept]
   723 E C0005767:Blood [Tissue]
   723 E C0005768:blood [Body Substance]
   723 E C0229664:Blood [Body Substance]
   723 E C0392895:Bloods [Population Group]
   704 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
   700 E C0333275:Bloody [Qualitative Concept]

Phrase: "(arrowhead in Fig 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0453107:Arrowhead [Food]
   770   C1080898:Arrowhead [Plant]

Phrase: ")."
Processing 00000000.tx.119: The A40 epitope was sometimes co-localized to the vessel wall, with an occasional continuity to these core-like structures. 

Phrase: "The A40 epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "was"

Phrase: "sometimes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Sometimes [Temporal Concept]

Phrase: "co-localized to the vessel wall,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0005847:Vessel [Body Part, Organ, or Organ Component]
   753   C0392752:Localized [Spatial Concept]
   753   C0677535:Wall [Manufactured Object]
   753   C1511228:Vessel [Tissue]

Phrase: "with an occasional continuity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0595960:Continuity [Qualitative Concept]
   789 E C0549178:Continuous [Idea or Concept]

Phrase: "to these core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]

Phrase: "like structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]
Processing 00000000.tx.120: Neuritic reactions, detected with AT8/rhodamine, were present around CWPs (asterisks in Fig 3, red), but they were rarely observed around the core-like structures (arrowheads in Fig 3) or the vessel wall (arrow in Fig 3). 

Phrase: "Neuritic reactions,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0443286:Reaction [Functional Concept]
   827   C1114821:Reaction [Clinical Attribute]

Phrase: "detected with AT8/rhodamine,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0442726:Detected [Finding]
   770   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "were"

Phrase: "present around CWPs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "(asterisks in Fig 3,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C2945706:asterisks [Conceptual Entity]

Phrase: "red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "they"

Phrase: "were"

Phrase: "rarely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522498:Rarely [Qualitative Concept]

Phrase: "observed around the core-"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0444669:Core [Spatial Concept]
   770   C1167518:core [Cell Component]
   770   C1441672:Observed [Functional Concept]
   770   C1706352:Core [Medical Device]
   770   C1882467:Core [Manufactured Object]
   770   C3274653:Core [Body Substance]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "(arrowheads in Fig 3"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1080898:Arrowheads [Plant]
   737 E C0453107:Arrowhead [Food]

Phrase: ")"

Phrase: "or"

Phrase: "the vessel wall"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0005847:Vessel [Body Part, Organ, or Organ Component]
   861   C0677535:Wall [Manufactured Object]
   861   C1511228:Vessel [Tissue]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "(arrow in Fig 3"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0336721:Arrow [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.121: As suggested by the stacked view of the 114 optical sections (Fig 4A), some of the core-like structures were occasionally clustered around blood vessels. 

Phrase: "As"

Phrase: "suggested by the stacked view of the 114 optical sections"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   739   C0449911:View [Spatial Concept]
   706   C0205155:Section [Spatial Concept]
   706   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   706   C1522472:Section [Substance]
   706   C1552923:Section [Quantitative Concept]
   706   C1705191:Section [Physical Object]
   706   C1705535:Suggest [Idea or Concept]
   706   C3272897:Stack [Spatial Concept]

Phrase: "(Fig 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "some of the core-"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0205392:Some [Quantitative Concept]
   770   C0444669:Core [Spatial Concept]
   770   C1167518:core [Cell Component]
   770   C1706352:Core [Medical Device]
   770   C1882467:Core [Manufactured Object]
   770   C3274653:Core [Body Substance]
   770   C3540770:Some [Intellectual Product]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "occasionally"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1998882:Occasionally [Temporal Concept]

Phrase: "clustered around blood vessels."
Meta Candidates (Total=14; Excluded=10; Pruned=0; Remaining=4)
   833   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   799 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   799 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   761 E C1558950:VASCULAR [Finding]
   761 E C1801960:Vascular [Qualitative Concept]
   740 E C0005767:Blood [Tissue]
   740 E C0005768:blood [Body Substance]
   740 E C0229664:Blood [Body Substance]
   740 E C0392895:Bloods [Population Group]
   737   C1555715:Cluster [Idea or Concept]
   737   C1704332:Cluster [Quantitative Concept]
   722 E C0333275:Bloody [Qualitative Concept]
Processing 00000000.tx.122: Three-dimensional observation with the software enabled us to examine a simultaneous stereoscopic view of these three epitopes (A40, PHF-tau, and blood vessel). 

Phrase: "Three-dimensional observation with the software"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0302523:Observation [Research Activity]
   753   C0700325:observation [Health Care Activity]
   753   C1964257:Observation [Diagnostic Procedure]

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "a simultaneous stereoscopic view of these three epitopes"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C2711609:Stereoscopic view [Spatial Concept]
   744   C0449911:View [Spatial Concept]

Phrase: "(A40,"

Phrase: "PHF-tau,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "and"

Phrase: "blood vessel"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
  1000   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
  1000   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   944 E C1558950:VASCULAR [Finding]
   944 E C1801960:Vascular [Qualitative Concept]
   916 E C0005767:Blood [Tissue]
   916 E C0005768:blood [Body Substance]
   916 E C0229664:Blood [Body Substance]
   916 E C0392895:Bloods [Population Group]
   893 E C0333275:Bloody [Qualitative Concept]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: ")."
Processing 00000000.tx.123: Finally, a cross-sectional view along an arbitrary cutting line on the blood vessel (from arrowhead to asterisk in Fig 4) showed that A40 accumulated around the blood vessel either in a linear or a spherical fashion (Fig 4E). 

Phrase: "Finally,"

Phrase: "a cross-sectional view along an arbitrary cutting line"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0449911:View [Spatial Concept]

Phrase: "on the blood vessel"
Meta Candidates (Total=13; Excluded=8; Pruned=0; Remaining=5)
  1000   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
  1000   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
  1000   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   944 E C1558950:VASCULAR [Finding]
   944 E C1801960:Vascular [Qualitative Concept]
   916 E C0005767:Blood [Tissue]
   916 E C0005768:blood [Body Substance]
   916 E C0229664:Blood [Body Substance]
   916 E C0392895:Bloods [Population Group]
   893 E C0333275:Bloody [Qualitative Concept]
   805 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "("

Phrase: "from arrowhead"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0453107:Arrowhead [Food]
  1000   C1080898:Arrowhead [Plant]

Phrase: "to asterisk"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945706:asterisk [Conceptual Entity]

Phrase: "in Fig 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that A40"

Phrase: "accumulated around the blood vessel either"
Meta Candidates (Total=11; Excluded=6; Pruned=0; Remaining=5)
   790   C0005847:Blood Vessel [Body Part, Organ, or Organ Component]
           Vessel
   790   C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   790   C1511228:VESSEL, BLOOD [Tissue]
           Vessel
   734 E C1558950:VASCULAR [Finding]
   734 E C1801960:Vascular [Qualitative Concept]
   706 E C0005767:Blood [Tissue]
   706 E C0005768:blood [Body Substance]
   706 E C0229664:Blood [Body Substance]
   706 E C0392895:Bloods [Population Group]

Phrase: "in a linear"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205132:Linear [Spatial Concept]

Phrase: "or"

Phrase: "a spherical fashion"

Phrase: "(Fig 4E"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450378:4e [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.124: Discussion Top Summary Introduction Materials and Methods Results Discussion Literature Cited We successfully performed triple immunofluorolabeling with two antibodies raised in rabbits and another mouse MAb. 

Phrase: "Discussion Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "We successfully"

Phrase: "performed"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0884358:Performed [Functional Concept]
   966 E C2947996:Perform [Pharmacologic Substance]

Phrase: "triple immunofluorolabeling with two antibodies"

Phrase: "raised in rabbits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0034493:Rabbit [Mammal]
   790   C0442818:Raised [Quantitative Concept]

Phrase: "and"

Phrase: "another mouse MAb."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   923   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   812   C0746619:monoclonal [Finding]
Processing 00000000.tx.125: Single immunofluorolabeling with different concentrations of the anti-A40 antibody clarified that the optimal dilution of the anti-A antibodies without CARD amplification was 1:1000, whereas equivalent labeling was obtained at a dilution of 1:30,000 after amplification with CARD. 

Phrase: "Single immunofluorolabeling with different concentrations of the anti-A40 antibody"

Phrase: "clarified"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986669:Clarified [Activity]

Phrase: "that"

Phrase: "the optimal dilution of the anti-A antibodies"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0079240:Dilution [Laboratory Procedure]
   744   C1948037:Dilution [Functional Concept]

Phrase: "without CARD amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "was"

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000,"

Phrase: "whereas"

Phrase: "equivalent labeling"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1167624:Labeling [Mental Process]
   861   C1947902:Labeling [Manufactured Object]
   861   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "was"

Phrase: "obtained at a dilution of 1"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0079240:Dilution [Laboratory Procedure]
   753   C1301820:Obtained [Functional Concept]
   753   C1948037:Dilution [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: ":"

Phrase: "30,000 after amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "with CARD."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposition [Functional Concept]
Processing 00000000.tx.126: One of the theoretical bases for discriminating two distinct epitopes with antibodies raised in the same species depends on this difference in the optimal concentration of the antibody for immunofluorescence study (Hunyady et al. 1996 ). 

Phrase: "One of the theoretical bases"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "for discriminating two distinct epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0003316:Epitopes [Immunologic Factor]

Phrase: "with antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   966 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "raised in the same species"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0442818:Raised [Quantitative Concept]
   760   C0445247:Same [Qualitative Concept]
   760   C1705920:Species [Conceptual Entity]

Phrase: "depends on this difference"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0725813:depend [Medical Device]
   770   C1705241:*Difference [Quantitative Concept]
   770   C1705242:Difference [Qualitative Concept]

Phrase: "in the optimal concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0086045:Concentration [Mental Process]
   861   C1446561:Concentration [Quantitative Concept]
   789 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "of the antibody"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
  1000   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for immunofluorescence study"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0016318:Immunofluorescence [Laboratory Procedure]
   861   C0079603:Immunofluorescence [Laboratory Procedure]
   861   C0557651:Study [Manufactured Object]
   861   C2603343:Study [Research Activity]
   805 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   789 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Hunyady et al. 1996"

Phrase: ")."
Processing 00000000.tx.127: The anti-A40 antibody in the first cycle was so diluted (1:30,000) that the corresponding epitope could be visualized only after the amplification, but visualization without amplification, as used in the second cycle, was not sensitive enough to detect this anti-A40 antibody diluted further to another 30-fold below the detection threshold. 

Phrase: "The anti-A40 antibody in the first cycle"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   744   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "was"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "(1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "30,000"

Phrase: ")"

Phrase: "that"

Phrase: "the corresponding epitope"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitope [Immunologic Factor]

Phrase: "could"

Phrase: "be"

Phrase: "visualized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0234621:Visualized [Functional Concept]

Phrase: "only after the amplification,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0205171:Only [Quantitative Concept]
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]
   770   C1720467:Only [Intellectual Product]

Phrase: "but"

Phrase: "visualization without amplification,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0175631:Visualization [Mental Process]
   790   C2827662:Visualization [Occupation or Discipline]

Phrase: "as"

Phrase: "used in the second cycle,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   797   C2348029:Cycle/Second [Quantitative Concept]
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1511572:Cycle [Temporal Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "was"

Phrase: "not sensitive enough to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   875   C0332324:Sensitive to [Functional Concept]
           Sensitive
   812   C1518422:Not [Functional Concept]
   812   C1550474:sensitive [Idea or Concept]

Phrase: "detect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442726:detect [Finding]

Phrase: "this anti-A40 antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "diluted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1720119:Dilute [Functional Concept]
   966   C1948037:Dilute [Functional Concept]

Phrase: "further to another 30-fold"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   760   C0332462:Fold [Spatial Concept]
   760   C1517331:Further [Spatial Concept]
   760   C1880834:FOLD [Phenomenon or Process]
   726 E C0205108:far [Spatial Concept]

Phrase: "below the detection threshold."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0449864:Threshold [Qualitative Concept]
Processing 00000000.tx.128: It is possible that the anti-rabbit antibody used in the first cycle before CARD amplification could be a source of crossreaction because it has an affinity for the other polyclonal antibody produced also in rabbit used in the second cycle. 

Phrase: "It"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "that"

Phrase: "the anti-rabbit antibody"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   913   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   901   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0034493:Rabbit [Mammal]

Phrase: "used in the first cycle"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0205435:First [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1279901:First [Qualitative Concept]
   760   C1511572:Cycle [Temporal Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "before CARD amplification"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1517480:Amplification [Molecular Biology Research Technique]
   812   C1521871:Amplification [Phenomenon or Process]
   812   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "could"

Phrase: "be"

Phrase: "a source of crossreaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449416:Source [Finding]
   770   C1705919:Source [Idea or Concept]

Phrase: "because"

Phrase: "it"

Phrase: "has"

Phrase: "an affinity for the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1510827:Affinity [Natural Phenomenon or Process]

Phrase: "other polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "produced"

Phrase: "also in rabbit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034493:Rabbit [Mammal]

Phrase: "used in the second cycle."
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   797   C2348029:Cycle/Second [Quantitative Concept]
   760   C0205436:Second [Quantitative Concept]
   760   C0457385:Second [Temporal Concept]
   760   C0565930:/second [Quantitative Concept]
   760   C1273517:used [Finding]
   760   C1511572:Cycle [Temporal Concept]
   760   C1561503:second [Idea or Concept]
   760   C1705190:Second [Qualitative Concept]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.129: Practically, this reaction was found to be less than the detection threshold, as demonstrated in Fig 2, which showed definite separation of the signals from A40 and A42 epitopes. 

Phrase: "Practically,"

Phrase: "this reaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443286:Reaction [Functional Concept]
  1000   C1114821:Reaction [Clinical Attribute]

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "less than the detection threshold,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C0439092:Less Than [Intellectual Product]
           less
   760   C0449864:Threshold [Qualitative Concept]
   760   C0547044:Less [Qualitative Concept]
   760   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "as"

Phrase: "demonstrated in Fig 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0349966:Fig [Food]
   770   C1337208:FIG [Food]

Phrase: "which"

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "definite separation of the signals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "from A40"

Phrase: "and"

Phrase: "A42 epitopes."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0003316:Epitopes [Immunologic Factor]
Processing 00000000.tx.130: Specific labelings were perfectly interchangeable when the two antibodies, anti-A40 and anti-A42, were replaced with each other (Fig 3), which provided additional evidence that crossreaction between the two epitopes was negligible. 

Phrase: "Specific labelings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1167624:Labeling [Mental Process]
   827   C1947902:Labeling [Manufactured Object]
   827   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "were"

Phrase: "perfectly interchangeable"

Phrase: "when"

Phrase: "the two antibodies,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "anti-A40"

Phrase: "and"

Phrase: "anti-A42,"

Phrase: "were"

Phrase: "replaced with each other"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0559956:Replaced [Functional Concept]
   770   C1299987:replaced [Functional Concept]
   737 E C1554078:Replace [Idea or Concept]

Phrase: "(Fig 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "which"

Phrase: "provided"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1999230:Provided [Activity]

Phrase: "additional evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0332120:Evidence [Functional Concept]

Phrase: "that crossreaction between the two epitopes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0010357:Cross Reaction [Molecular Function]

Phrase: "was"

Phrase: "negligible."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332269:Negligible [Qualitative Concept]
Processing 00000000.tx.131: The absence of crossreaction may be explained by the low concentration of the first primary antibody, which attracts, if any, a very tiny amount of the anti-rabbit antibody. 

Phrase: "The absence of crossreaction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]

Phrase: "may"

Phrase: "be"

Phrase: "explained by the low concentration of the first primary antibody,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   739   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   739   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   739   C0086045:Concentration [Mental Process]
   739   C0205225:Primary [Qualitative Concept]
   739   C0205251:low [Qualitative Concept]
   739   C0205435:First [Quantitative Concept]
   739   C0439631:Primary [Therapeutic or Preventive Procedure]
   739   C1279901:First [Qualitative Concept]
   739   C1299352:Low [Qualitative Concept]
   739   C1446561:Concentration [Quantitative Concept]
   739   C1550472:low [Idea or Concept]

Phrase: "which"

Phrase: "attracts"

Phrase: ","

Phrase: "if"

Phrase: "any,"

Phrase: "a very tiny"

Phrase: "amount of the anti-rabbit antibody."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0034493:Rabbit [Mammal]
   753   C1265611:Amount [Quantitative Concept]
Processing 00000000.tx.132: This amount of the anti-rabbit antibody should be far below the detection threshold even if the second polyclonal antibody is attached to it. 

Phrase: "This amount of the anti-rabbit antibody"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "should"

Phrase: "be"

Phrase: "far below the detection threshold even"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0205108:far [Spatial Concept]
   753   C0449864:Threshold [Qualitative Concept]
   753   C1511790:Detection [Therapeutic or Preventive Procedure]

Phrase: "if"

Phrase: "the second polyclonal antibody"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "is"

Phrase: "attached to it."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0231441:Attached [Finding]
   756 E C1314972:ATTACH [Intellectual Product]
Processing 00000000.tx.133: Wide separation of the emission signals from FITC and from Cy5 made it possible to insert another emission signal from rhodamine without crosstalk between them (Table 2), because rhodamine was designed to label another monoclonal antibody, AT8, through anti-mouse IgG, which never crossreacts with the other two polyclonal antibodies produced in rabbits. 

Phrase: "Wide separation of the emission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0036679:Separation [Pathologic Function]
   760   C0237868:Separation [Social Behavior]
   760   C1881713:SEPARATION [Phenomenon or Process]

Phrase: "signals from FITC"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0085216:FITC [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1710082:Signal [Phenomenon or Process]

Phrase: "and from Cy5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0250829:Cy5 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   790   C1515981:And [Idea or Concept]

Phrase: "made"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1881534:Make [Functional Concept]

Phrase: "it possible to"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332149:Possible [Qualitative Concept]
   861   C1705910:Possible [Qualitative Concept]
   861   C2362652:Possible [Qualitative Concept]

Phrase: "insert"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441587:Insert [Health Care Activity]
  1000   C1743766:Insert [Medical Device]
  1000   C1883719:Insert [Functional Concept]

Phrase: "another emission signal from rhodamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "without crosstalk"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0010357:Crosstalk [Molecular Function]
  1000   C2986468:Cross-talk [Cell Function]

Phrase: "between them"

Phrase: "(Table 2"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "rhodamine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600322:Rhodamine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "was"

Phrase: "designed to label"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0181496:Label [Manufactured Object]
   790   C2827499:Label [Governmental or Regulatory Activity]
   756   C1707689:Design [Activity]
   756   C2983265:DESIGN [Intellectual Product]

Phrase: "another monoclonal antibody,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   861   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   861   C0746619:monoclonal [Finding]

Phrase: "AT8,"

Phrase: "through anti-mouse IgG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   913   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "which never"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2003901:Never [Temporal Concept]

Phrase: "crossreacts with the"

Phrase: "other two polyclonal antibodies"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   867   C0312586:Polyclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "produced in rabbits."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0034493:Rabbit [Mammal]
Processing 00000000.tx.134: These triple-labeled sections demonstrated that most of the CWPs were homogeneously stained with the anti-A42 antibody (Crook et al. 1998 ; Le et al. 2001 ; Steiner et al. 2001 ; Verkkoniemi et al. 2001 ; Tabira et al. 2002 ). 

Phrase: "These triple-labeled sections"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   793   C0205155:Section [Spatial Concept]
   793   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   793   C1522472:Section [Substance]
   793   C1552923:Section [Quantitative Concept]
   793   C1705191:Section [Physical Object]

Phrase: "demonstrated"

Phrase: "that most of the CWPs"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   778   C0440207:Cotton wool [Biomedical or Dental Material]
   748   C0010196:Cotton [Plant]
   748   C0043220:Wool [Substance]
   748   C0330523:cotton [Plant]
   748   C0330524:cotton [Plant]
   748   C0333463:plaques [Acquired Abnormality]
   748   C1095832:Cotton [Substance]
   748   C1561494:Wool [Intellectual Product]
   714 E C0011389:Plaque [Disease or Syndrome]
   714 E C0332461:Plaque [Finding]

Phrase: "were"

Phrase: "homogeneously"

Phrase: "stained with the anti-A42 antibody"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C2986582:Stained [Qualitative Concept]
   719 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(Crook et al. 1998"

Phrase: "; Le et al. 2001"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0439090:LE [Idea or Concept]
   812   C1423767:LE [Gene or Genome]

Phrase: "; Steiner et al. 2001"

Phrase: "; Verkkoniemi et al. 2001"

Phrase: "; Tabira et al. 2002"

Phrase: ")."
Processing 00000000.tx.135: One of the intriguing findings was that core-like structures were intensely labeled with the anti-A40 antibody. 

Phrase: "One of the intriguing findings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "was"

Phrase: "that core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "intensely"

Phrase: "labeled with the anti-A40 antibody."
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]
Processing 00000000.tx.136: These core-like structures were rare in deeper cortical layers of the cerebral cortex (Fig 2B) and were not necessarily associated with deposits of A42. 

Phrase: "These core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "rare in deeper cortical layers of the cerebral cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0521114:Rare [Temporal Concept]
   742   C0522498:Rare [Qualitative Concept]
   742   C1514917:RARE [Gene or Genome]

Phrase: "(Fig 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: "and"

Phrase: "were"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "associated with deposits of A42."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   806   C0332281:Associated with [Qualitative Concept]
           Associated
   760   C0333562:Deposits [Functional Concept]
   726 E C0750490:Associate [Idea or Concept]
   726 E C1706221:Associate [Professional or Occupational Group]
Processing 00000000.tx.137: Although a possible spatial relationship of these core-like structures to blood vessels was suspected even with two-dimensional observation (Fig 3), 3D reconstruction confirmed that they were sometimes in continuity with blood vessels similarly labeled with the anti-A40 antibody (Fig 4). 

Phrase: "Although"

Phrase: "a possible spatial relationship of these core-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439849:Relationship [Qualitative Concept]
   748   C1705630:Relationship [Idea or Concept]
   748   C1706279:Relationship [Idea or Concept]
   748   C3540605:Relationship [Intellectual Product]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "to blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "was"

Phrase: "suspected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332147:Suspected [Qualitative Concept]
  1000   C0750491:Suspected [Idea or Concept]
   966 E C1571873:Suspect [Idea or Concept]

Phrase: "even with two-dimensional observation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   806   C1705052:2-Dimensional [Spatial Concept]
   760   C0205448:Two [Quantitative Concept]
   760   C0302523:Observation [Research Activity]
   760   C0700325:observation [Health Care Activity]
   760   C1964257:Observation [Diagnostic Procedure]

Phrase: "(Fig 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "3D reconstruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0020912:Reconstruction [Machine Activity]
   861   C0524865:Reconstruction [Therapeutic or Preventive Procedure]

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "they"

Phrase: "were"

Phrase: "sometimes in continuity with blood vessels similarly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0595960:Continuity [Qualitative Concept]

Phrase: "labeled with the anti-A40 antibody"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C1708632:Labeled [Qualitative Concept]
   719 E C0181496:Label [Manufactured Object]
   719 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(Fig 4"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.138: Furthermore, this reconstruction enabled us to observe cross-sectional images not only along the X, Y, or Z axis but also along an arbitrary line tracing the target structure, e.g., blood vessels as shown in Fig 4E. 

Phrase: "Furthermore,"

Phrase: "this reconstruction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0020912:Reconstruction [Machine Activity]
  1000   C0524865:Reconstruction [Therapeutic or Preventive Procedure]

Phrase: "enabled"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0562342:Enabled [Mental Process]
   966 E C1171285:enable [Mental Process]

Phrase: "us to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "observe"

Phrase: "cross-sectional images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]

Phrase: "not only along the X,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205171:Only [Quantitative Concept]
   760   C1518422:Not [Functional Concept]
   760   C1720467:Only [Intellectual Product]

Phrase: "Y,"

Phrase: "or"

Phrase: "Z axis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0004457:Axis [Body Part, Organ, or Organ Component]
   861   C0999597:Axis [Mammal]
   861   C1522496:Axis [Spatial Concept]

Phrase: "but"

Phrase: "also along an arbitrary line"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0205132:Line [Spatial Concept]
   760   C1264693:*Arbitrary [Quantitative Concept]
   760   C1550648:Line [Substance]
   760   C1552960:Line [Quantitative Concept]

Phrase: "tracing"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0442822:Trace [Quantitative Concept]
   966   C1524031:Trace [Qualitative Concept]
   966   C1883002:Trace [Functional Concept]

Phrase: "the target structure,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0678594:Structure [Spatial Concept]
   861   C1521840:Target [Functional Concept]
   861   C2986546:TARGET [Diagnostic Procedure]

Phrase: "e.g."

Phrase: ","

Phrase: "blood vessels"
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]

Phrase: "as"

Phrase: "shown in Fig 4E."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0349966:Fig [Food]
   770   C0450378:4e [Intellectual Product]
   770   C1337208:FIG [Food]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.139: No similar relationship to blood vessels was evident with A42-positive CWPs. 

Phrase: "No similar relationship to blood vessels"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0439849:Relationship [Qualitative Concept]
   753   C1705630:Relationship [Idea or Concept]
   753   C1706279:Relationship [Idea or Concept]
   753   C3540605:Relationship [Intellectual Product]

Phrase: "was"

Phrase: "evident with A42-positive CWPs."
Processing 00000000.tx.140: Simultaneous labeling with AT8/rhodamine demonstrated that AT8-positive neurites were slender, without focal swelling, and were abundant around CWPs but rarely associated with the core-like structures. 

Phrase: "Simultaneous labeling with AT8/rhodamine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1167624:Labeling [Mental Process]
   760   C1947902:Labeling [Manufactured Object]
   760   C2827499:Labeling [Governmental or Regulatory Activity]

Phrase: "demonstrated"

Phrase: "that AT8-positive neurites"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0085103:Neurites [Cell Component]

Phrase: "were"

Phrase: "slender,"

Phrase: "without focal swelling,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0013604:SWELLING [Pathologic Function]
   861   C0038999:Swelling [Finding]
   768 E C1709317:Oncosis [Cell Function]

Phrase: "and"

Phrase: "were"

Phrase: "abundant around CWPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C2346714:Abundant [Qualitative Concept]

Phrase: "but"

Phrase: "rarely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522498:Rarely [Qualitative Concept]

Phrase: "associated with the core-"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   833   C0332281:Associated with [Qualitative Concept]
           Associated
   770   C0444669:Core [Spatial Concept]
   770   C1167518:core [Cell Component]
   770   C1706352:Core [Medical Device]
   770   C1882467:Core [Manufactured Object]
   770   C3274653:Core [Body Substance]
   737 E C0750490:Associate [Idea or Concept]
   737 E C1706221:Associate [Professional or Occupational Group]

Phrase: "like structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]
Processing 00000000.tx.141: Furthermore, AT8-positive structures were uniformly scattered throughout the entire thickness of the sections, providing proof that this triple immunofluorolabeling reliably and homogeneously detected the structures in question under the present experimental conditions applied to the thick sections. 

Phrase: "Furthermore,"

Phrase: "AT8-positive structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0678594:structures [Spatial Concept]

Phrase: "were"

Phrase: "uniformly"

Phrase: "scattered throughout the entire thickness of the sections,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   744   C0439742:Scattered [Spatial Concept]
   744   C0439751:Entire [Quantitative Concept]
   744   C0444667:Entire [Quantitative Concept]
   744   C1280412:Thickness [Qualitative Concept]
   711   C0205155:Section [Spatial Concept]
   711   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   711   C1522472:Section [Substance]
   711   C1552923:Section [Quantitative Concept]
   711   C1705191:Section [Physical Object]

Phrase: "providing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1999230:Provide [Activity]

Phrase: "proof"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0556981:% proof [Quantitative Concept]

Phrase: "that"

Phrase: "this triple immunofluorolabeling reliably"

Phrase: "and"

Phrase: "homogeneously"

Phrase: "detected"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0442726:Detected [Finding]
  1000   C1511790:Detected [Therapeutic or Preventive Procedure]

Phrase: "the structures in question"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0678594:structures [Spatial Concept]

Phrase: "under the present experimental conditions"
Meta Candidates (Total=13; Excluded=9; Pruned=0; Remaining=4)
   827   C1517586:Experimental [Qualitative Concept]
   793   C0012634:condition [Disease or Syndrome]
   793   C0348080:Condition [Qualitative Concept]
   793   C1705253:Condition [Conceptual Entity]
   771 E C0040607:Training [Educational Activity]
   771 E C0220931:Training [Educational Activity]
   771 E C0336809:Train [Manufactured Object]
   771 E C1552514:Train [Manufactured Object]
   771 E C2673163:training [Qualitative Concept]
   743 E C0009647:Conditioned [Mental Process]
   743 E C1701901:Conditional [Qualitative Concept]
   743 E C1963686:Conditional [Functional Concept]
   721 E C1519605:Conditionality [Conceptual Entity]

Phrase: "applied to the thick sections."
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0185125:Applied [Health Care Activity]
   760   C1280412:Thick [Qualitative Concept]
   726   C0205155:Section [Spatial Concept]
   726   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
   726   C1522472:Section [Substance]
   726   C1552923:Section [Quantitative Concept]
   726 E C1632850:Apply [Functional Concept]
   726   C1705191:Section [Physical Object]
   726 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.142: Morphology, immunohistochemical features, and association of tau-positive neurites were found to be different in A42-positive CWPs from those in A40-positive core-like structures and blood vessels. 

Phrase: "Morphology,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0332437:Morphology [Qualitative Concept]
  1000   C0543482:morphology [Spatial Concept]
  1000   C0700329:Morphology, NOS [Finding]
  1000   C0700619:Morphology [Biomedical Occupation or Discipline]

Phrase: "immunohistochemical features,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "association of tau-positive neurites"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0004083:Association [Mental Process]
   760   C0439849:Association [Qualitative Concept]
   760   C0596306:Association [Phenomenon or Process]
   760   C0699792:association [Social Behavior]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "different in A42-positive CWPs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1705242:Different [Qualitative Concept]

Phrase: "from those in A40-positive core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0444669:Core [Spatial Concept]
   812   C1167518:core [Cell Component]
   812   C1706352:Core [Medical Device]
   812   C1882467:Core [Manufactured Object]
   812   C3274653:Core [Body Substance]

Phrase: "like structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]

Phrase: "and"

Phrase: "blood vessels."
Meta Candidates (Total=13; Excluded=11; Pruned=0; Remaining=2)
  1000   C0005847:Blood Vessels [Body Part, Organ, or Organ Component]
           Vessels
   966 E C1283786:Blood vessel [Body Part, Organ, or Organ Component]
   966 E C1511228:VESSEL, BLOOD [Tissue]
       E   Vessel
   928 E C1558950:VASCULAR [Finding]
   928 E C1801960:Vascular [Qualitative Concept]
   907 E C0005767:Blood [Tissue]
   907 E C0005768:blood [Body Substance]
   907 E C0229664:Blood [Body Substance]
   907 E C0392895:Bloods [Population Group]
   888 E C0333275:Bloody [Qualitative Concept]
   789 E C0702235:Vasal [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.143: These differences suggest that mechanisms involved in A deposition may be different in these structures found in the same microscopic field. 

Phrase: "These differences"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   966   C1705241:*Difference [Quantitative Concept]
   966   C1705242:Difference [Qualitative Concept]
   916 E C0443199:Differential [Qualitative Concept]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0441712:Mechanisms [Functional Concept]
   966 E C1706376:Mechanism [Manufactured Object]

Phrase: "involved in A deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0333562:Deposition [Functional Concept]
   770   C1314939:Involved [Functional Concept]

Phrase: "may"

Phrase: "be"

Phrase: "different in these structures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1705242:Different [Qualitative Concept]

Phrase: "found in the same microscopic field."
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   753   C0150312:Found [Quantitative Concept]
   753   C0205288:Microscopic [Qualitative Concept]
   753   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   753   C0445247:Same [Qualitative Concept]
   753   C1521738:Field [Conceptual Entity]
   753   C2346620:Field [Conceptual Entity]
   753   C2349184:Field [Conceptual Entity]
   753   C3539073:FIELD [Spatial Concept]
   719 E C0243095:Find [Finding]
Processing 00000000.tx.144: In summary, we established a triple-immunofluorolabeling method with two rabbit polyclonal antibodies and a mouse monoclonal antibody, which simultaneously visualized A40, A42, or von Willebrand factor and PHF-tau epitopes. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "established"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0443211:Established [Qualitative Concept]
  1000   C1272684:Established [Qualitative Concept]

Phrase: "a triple-immunofluorolabeling method with two rabbit polyclonal antibodies"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0025663:Method [Intellectual Product]
   742   C0449851:Method [Functional Concept]
   742   C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "a mouse monoclonal antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   901   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   827   C0746619:monoclonal [Finding]

Phrase: "which simultaneously visualized A40,"

Phrase: "A42,"

Phrase: "or"

Phrase: "von Willebrand factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0042971:von Willebrand Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
  1000   C1336938:VON WILLEBRAND FACTOR [Gene or Genome]
   901   C0042974:von Willebrand [Disease or Syndrome]
   827   C1521761:Factor [Functional Concept]
   827   C2827422:Factor [Conceptual Entity]

Phrase: "and"

Phrase: "PHF-tau epitopes."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0003316:Epitopes [Immunologic Factor]
   734   C2700455:PHF-Tau [Amino Acid, Peptide, or Protein]
Processing 00000000.tx.145: Application of this triple immunofluorolabeling enabled thick sections to be analyzed on a 3D basis. 

Phrase: "Application of this triple immunofluorolabeling enabled thick sections to"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0185125:Application [Health Care Activity]
   742   C1947919:Application [Intellectual Product]
   742   C2347934:Application [Intellectual Product]
   742   C3539080:APPLICATION [Quantitative Concept]

Phrase: "be"

Phrase: "analyzed on a 3D basis."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0450363:3D [Spatial Concept]
   760   C0936012:Analyzed [Research Activity]
   760   C1527178:Basis [Functional Concept]
   760   C1874451:Basis [Pharmacologic Substance]
   760   C2986797:3D [Functional Concept]
Processing 00000000.tx.146: Immunohistochemical features and distribution were found to be different between A42-positive deposits and their A40-positive counterparts. 

Phrase: "Immunohistochemical features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "and"

Phrase: "distribution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0520511:distribution [Idea or Concept]
  1000   C1704711:Distribution [Functional Concept]

Phrase: "were"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "different between A42-positive deposits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "and"

Phrase: "their A40-positive counterparts."
Processing 00000000.tx.147: This suggests that the mechanism of A deposition for CWPs is different from that of other A deposits, such as core-like structures. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the mechanism of A deposition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]

Phrase: "for CWPs"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   734   C0440207:Cotton wool [Biomedical or Dental Material]

Phrase: "is"

Phrase: "different from that of other"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1705242:Different [Qualitative Concept]

Phrase: "A deposits,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0333562:Deposits [Functional Concept]

Phrase: "such as core-"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0444669:Core [Spatial Concept]
  1000   C1167518:core [Cell Component]
  1000   C1706352:Core [Medical Device]
  1000   C1882467:Core [Manufactured Object]
  1000   C3274653:Core [Body Substance]

Phrase: "like structures."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0678594:structures [Spatial Concept]
Processing 00000000.tx.148: This triple-labeling method will expand the applicability and precision of multiple immunoflurolabeling, which is advantageous in a wide range of research and diagnosis. 

Phrase: "This triple-labeling method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025663:Method [Intellectual Product]
   827   C0449851:Method [Functional Concept]
   827   C0871511:METHOD [Intellectual Product]

Phrase: "will"

Phrase: "expand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205229:Expand [Spatial Concept]

Phrase: "the applicability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   928   C1272460:applicable [Qualitative Concept]
   928   C1706839:Applicable [Qualitative Concept]

Phrase: "and"

Phrase: "precision of multiple immunoflurolabeling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1547902:Precision [Temporal Concept]
   770   C1706245:Precision [Qualitative Concept]

Phrase: "which"

Phrase: "is"

Phrase: "advantageous in a wide range of research"

Phrase: "and"

Phrase: "diagnosis."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0011900:Diagnosis [Finding]
  1000   C1704338:diagnosis [Qualitative Concept]
  1000   C1704656:DIAGNOSIS [Research Activity]
Processing 00000000.tx.149: Acknowledgments Supported in part by a grant (TU) from the Ministry of Culture, Sports, Science and Technology, Japan. 

Phrase: "Acknowledgments"

Phrase: "Supported in part"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   790   C0449719:Part [Spatial Concept]
   790   C1521721:Supported [Conceptual Entity]
   790   C1709471:Part [Quantitative Concept]
   756 E C0183683:Support [Medical Device]

Phrase: "by a grant"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0018173:Grant [Quantitative Concept]
  1000   C1548284:Grant [Idea or Concept]

Phrase: "(TU) from the Ministry of Culture,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1532464:TU [Quantitative Concept]
   753   C2700314:TU [Fish]

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.150: We are grateful to Mr Ray Cowan for reading the manuscript. 

Phrase: "We"

Phrase: "are"

Phrase: "grateful to Mr Ray Cowan"

Phrase: "for reading"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034754:Reading [Daily or Recreational Activity]
  1000   C1705179:Reading [Finding]

Phrase: "the manuscript."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0600659:Manuscript [Intellectual Product,Manufactured Object]
Processing 00000000.tx.151: Received for publication November 5, 2002; 

Phrase: "Received for publication November 5,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0034036:Publication [Intellectual Product,Manufactured Object]
   760   C0034037:Publication [Occupational Activity]
   760   C1514756:Received [Qualitative Concept]
   760   C1704324:Publication [Intellectual Product]

Phrase: "2002"

Phrase: ";"
Processing 00000000.tx.152: accepted April 2, 2003. 

Phrase: "accepted April 2,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1272684:Accepted [Qualitative Concept]
   827   C1548435:Accepted [Idea or Concept]

Phrase: "2003."
Processing 00000000.tx.153: Literature Cited Top Summary Introduction Materials and Methods Results Discussion Literature Cited Adams JC (1992) Biotin amplification of biotin and horseradish peroxidase signals in histochemical stains. 

Phrase: "Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0023866:Literature [Intellectual Product]
  1000   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Top Summary Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion Literature"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0023866:Literature [Intellectual Product]
   812   C0034036:LITERATURE [Intellectual Product,Manufactured Object]

Phrase: "Cited"

Phrase: "Adams JC"

Phrase: "(1992"

Phrase: ")"

Phrase: "Biotin amplification of biotin"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1517480:Amplification [Molecular Biology Research Technique]
   770   C1521871:Amplification [Phenomenon or Process]
   770   C1705759:Amplification [Cell or Molecular Dysfunction]

Phrase: "and"

Phrase: "horseradish peroxidase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
  1000   C0019941:Horseradish Peroxidase [Amino Acid, Peptide, or Protein,Enzyme,Indicator, Reagent, or Diagnostic Aid]
   861   C0027021:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0031179:Peroxidase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0330510:Horseradish [Food]
   861   C0939835:HORSERADISH [Organic Chemical,Pharmacologic Substance]
   861   C1110641:Horseradish [Plant]
   861   C1318719:Peroxidase [Indicator, Reagent, or Diagnostic Aid]

Phrase: "signals in histochemical stains."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0038128:Stains [Indicator, Reagent, or Diagnostic Aid]
   770   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.154: J Histochem Cytochem 40:1457-1463[Abstract/Free FullText] Akiyama H, Mori H, Sahara N, Kondo H, Ikeda K, Nishimura T, Oda T et al. 

Phrase: "J Histochem Cytochem 40"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439509:/40 [Temporal Concept]

Phrase: ":"

Phrase: "1457-1463"

Phrase: "[Abstract/Free FullText"

Phrase: "] Akiyama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mori H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Sahara N,"

Phrase: "Kondo H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ikeda K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Nishimura T,"

Phrase: "Oda T et al."
Processing 00000000.tx.155: (1997) Variable deposition of amyloid -protein (A) with the carboxy-terminus that ends at residue valine 40 (A40) in the cerebral cortex of patients with Alzheimer's disease: a double-labeling immunohistochemical study with antibodies specific for A40 and the A that ends at residues alanine 42/threonine43 (A42). 

Phrase: "(1997"

Phrase: ")"

Phrase: "Variable deposition of amyloid -protein (A"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0011560:Amyloid deposition [Pathologic Function]
   783   C0333584:Protein deposition [Pathologic Function]
   783   C1705760:Amyloid Deposition [Finding]
   753   C0333562:Deposition [Functional Concept]

Phrase: ")"

Phrase: "with the carboxy-terminus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0596260:Carboxy [Organic Chemical]

Phrase: "that ends at residue valine 40"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   753   C0444930:ends [Spatial Concept]
   719 E C2746065:End [Temporal Concept]

Phrase: "(A40"

Phrase: ")"

Phrase: "in the cerebral cortex"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0007776:Cerebral cortex [Body Part, Organ, or Organ Component]
           Cortex
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "of patients"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0030705:Patients [Patient or Disabled Group]

Phrase: "with Alzheimer's disease"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C0002395:Alzheimer's Disease [Disease or Syndrome]
  1000   C1521724:Alzheimer's Disease [Pathologic Function]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]

Phrase: ":"

Phrase: "a double-labeling immunohistochemical study with antibodies"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   757   C0580327:antibody study [Laboratory Procedure]
   748   C0557651:Study [Manufactured Object]
   748   C1441616:Immunohistochemical [Laboratory Procedure]
   748   C2603343:Study [Research Activity]

Phrase: "specific for A40"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0205369:Specific [Qualitative Concept]
   790   C1552740:specific [Intellectual Product]

Phrase: "and"

Phrase: "the A"

Phrase: "that"

Phrase: "ends at residues alanine 42/threonine43"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0001898:Alanine [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C0444930:End [Spatial Concept]
   753   C2746065:End [Temporal Concept]
   719   C1709915:Residue [Conceptual Entity]
   719   C1882936:RESIDUE [Phenomenon or Process]

Phrase: "(A42"

Phrase: ")."
Processing 00000000.tx.156: Neurochem Res 22:1499-1506[Medline] Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ (1989) Catalyzed reporter deposition, a novel method of signal amplification. 

Phrase: "Neurochem Res 22"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2347379:RES [Finding]

Phrase: ":"

Phrase: "1499-1506"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bobrow MN,"

Phrase: "Harris TD,"

Phrase: "Shaughnessy KJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439255:kJ [Quantitative Concept]

Phrase: "Litt GJ (1989"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C2346650:LITT [Therapeutic or Preventive Procedure]

Phrase: ")"

Phrase: "Catalyzed reporter deposition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposition [Functional Concept]

Phrase: "a novel method of signal amplification."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.157: Application to immunoassays. 

Phrase: "Application to immunoassays."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0185125:Application [Health Care Activity]
   790   C1947919:Application [Intellectual Product]
   790   C2347934:Application [Intellectual Product]
   790   C3539080:APPLICATION [Quantitative Concept]
Processing 00000000.tx.158: J Immunol Methods 125:279-285[Medline] Crook R, Verkkoniemi A, PerezTur J, Mehta N, Baker M, Houlden H, Farrer M et al. 

Phrase: "J Immunol Methods 125"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "279-285"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Crook R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Verkkoniemi A,"

Phrase: "PerezTur J,"

Phrase: "Mehta N,"

Phrase: "Baker M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Houlden H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Farrer M et al."
Processing 00000000.tx.159: (1998) A variant of Alzheimer's disease with spastic paraparesis and unusual plaques due to deletion of exon 9 of presenilin 1. 

Phrase: "(1998"

Phrase: ")"

Phrase: "A variant of Alzheimer's disease"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205419:Variant [Qualitative Concept]

Phrase: "with spastic paraparesis"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0037771:Paraparesis, Spastic [Sign or Symptom]
   861   C0221166:Paraparesis [Sign or Symptom]

Phrase: "and"

Phrase: "unusual plaques due to deletion of exon 9 of presenilin 1."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   738   C0333463:plaques [Acquired Abnormality]
   704 E C0011389:Plaque [Disease or Syndrome]
   704 E C0332461:Plaque [Finding]
Processing 00000000.tx.160: Nature Med 4:452-455[Medline] Hunyady B, Krempels K, Harta G, Mezey E (1996) Immunohistochemical signal amplification by catalyzed reporter deposition and its amplification in double immunostaining. 

Phrase: "Nature Med 4"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0349590:Nature [Idea or Concept]
   827   C1262865:Nature [Functional Concept]
   755 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "452-455"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hunyady B,"

Phrase: "Krempels K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Harta G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Mezey E (1996"

Phrase: ")"

Phrase: "Immunohistochemical signal amplification by catalyzed reporter deposition"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C1517480:Amplification [Molecular Biology Research Technique]
   748   C1521871:Amplification [Phenomenon or Process]
   748   C1705759:Amplification [Cell or Molecular Dysfunction]
   748   C1710082:Signal [Phenomenon or Process]

Phrase: "and"

Phrase: "its amplification in double immunostaining."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C1517480:Amplification [Molecular Biology Research Technique]
   760   C1521871:Amplification [Phenomenon or Process]
   760   C1705759:Amplification [Cell or Molecular Dysfunction]
Processing 00000000.tx.161: J Histochem Cytochem 44:1353-1362[Abstract] Iwatsubo T, Odaka A, Suzuki N, Mizusawa H, Nukina N, Ihara Y (1994) Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). 

Phrase: "J Histochem Cytochem 44"

Phrase: ":"

Phrase: "1353-1362"

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Iwatsubo T,"

Phrase: "Odaka A,"

Phrase: "Suzuki N,"

Phrase: "Mizusawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Nukina N,"

Phrase: "Ihara Y (1994"

Phrase: ")"

Phrase: "Visualization of A beta 42"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0175631:Visualization [Mental Process]
   760   C2827662:Visualization [Occupation or Discipline]

Phrase: "(43"

Phrase: ")"

Phrase: "and"

Phrase: "A beta 40 in senile plaques"
Meta Candidates (Total=10; Excluded=2; Pruned=0; Remaining=8)
   790   C0333463:Senile Plaques [Acquired Abnormality]
           plaques
   790   C1420510:A-BETA [Gene or Genome]
   753   C0330390:Beta [Plant]
   753   C0392079:Senile [Finding]
   753   C0439096:Beta [Intellectual Product]
   753   C0439509:/40 [Temporal Concept]
   753   C2004068:Beta [Qualitative Concept]
   719 E C0011389:Plaque [Disease or Syndrome]
   719 E C0332461:Plaque [Finding]

Phrase: "with end-specific A beta monoclonals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   771   C0746619:monoclonal [Finding]

Phrase: ":"

Phrase: "evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that"

Phrase: "an initially deposited species"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1705920:Species [Conceptual Entity]

Phrase: "is"

Phrase: "A beta 42"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   901   C1420510:A-BETA [Gene or Genome]
   827   C0330390:Beta [Plant]
   827   C0439096:Beta [Intellectual Product]
   827   C2004068:Beta [Qualitative Concept]

Phrase: "(43"

Phrase: ")."
Processing 00000000.tx.162: Neuron 13:45-53[Medline] Kitamoto T, Ogomori K, Tateishi J, Prusiner SB (1987) Formic acid pretreatment enhances immunostaining of cerebral and systemic amyloids. 

Phrase: "Neuron 13"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "45-53"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kitamoto T,"

Phrase: "Ogomori K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Tateishi J,"

Phrase: "Prusiner SB (1987"

Phrase: ")"

Phrase: "Formic acid pretreatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C1550147:Pretreatment [Substance]
   827   C2709094:pre treatment [Temporal Concept]
   827   C3539075:Pretreatment [Temporal Concept]
   827   C3539076:Pretreatment [Activity]
   734   C0016576:formic acid [Indicator, Reagent, or Diagnostic Aid,Organic Chemical,Pharmacologic Substance]
   734   C0885348:formic acid [Organic Chemical]

Phrase: "enhances"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "immunostaining of cerebral"

Phrase: "and"

Phrase: "systemic amyloids."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0002716:amyloids [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827 E C0011560:Amyloid [Pathologic Function]
   827 E C0611285:Amyloid [Amino Acid, Peptide, or Protein,Biologically Active Substance]
Processing 00000000.tx.163: Lab Invest 57:230-236[Medline] Lan HY, David WM, NikolicPaterson DJ, Atkins RC (1995) A novel, simple, reliable, and sensitive method for multiple immunoenzyme staining: use of microwave oven heating to block antibody crossreactivity and retrieve antigens. 

Phrase: "Lab"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0022877:Lab [Manufactured Object,Organization]
   944 E C0035100:Rennin [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   916 E C0587081:Labs [Finding]

Phrase: "Invest"

Phrase: "57"

Phrase: ":"

Phrase: "230-236"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lan HY,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1539791:HY [Gene or Genome]

Phrase: "David WM,"

Phrase: "NikolicPaterson DJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0012836:DJ [Geographic Area]

Phrase: "Atkins RC (1995"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1419366:RC [Gene or Genome]

Phrase: ")"

Phrase: "A novel, simple, reliable,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   755   C2347947:Reliability [Quantitative Concept]

Phrase: "and"

Phrase: "sensitive method for multiple immunoenzyme staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   783   C0487602:Staining method [Laboratory Procedure]
   753   C0025663:Method [Intellectual Product]
   753   C0449851:Method [Functional Concept]
   753   C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "use of microwave oven"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   833   C1524063:Use of [Functional Concept]
   770   C0042153:use [Functional Concept]
   770   C0457083:Use [Functional Concept]
   770   C1947944:Use [Intellectual Product]

Phrase: "heating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0018851:Heating [Environmental Effect of Humans]
   966 E C0018837:Heat [Natural Phenomenon or Process]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "antibody crossreactivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0010357:Cross Reactivity [Molecular Function]
   861   C0872139:cross reactivity [Molecular Function]
   861   C1880190:CROSS REACTIVITY [Event]

Phrase: "and"

Phrase: "retrieve"

Phrase: "antigens."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0003320:Antigens [Immunologic Factor]
   893 E C2698667:ANTIGENICITY [Regulation or Law]
Processing 00000000.tx.164: J Histochem Cytochem 43:97-102[Abstract/Free FullText] Le TV, Crook R, Hardy J, Dickson DW (2001) Cotton wool plaques in non-familial late-onset Alzheimer disease. 

Phrase: "J Histochem Cytochem 43"

Phrase: ":"

Phrase: "97-102"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0439073:97 [Intellectual Product]
   861   C0439082:>97 [Quantitative Concept]

Phrase: "[Abstract/Free FullText"

Phrase: "] Le TV,"

Phrase: "Crook R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Hardy J,"

Phrase: "Dickson DW (2001"

Phrase: ")"

Phrase: "Cotton wool plaques in non-familial late-onset Alzheimer disease."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   739   C0333463:plaques [Acquired Abnormality]
   706 E C0011389:Plaque [Disease or Syndrome]
   706 E C0332461:Plaque [Finding]
Processing 00000000.tx.165: J Neuropathol Exp Neurol 60:1051-1061[Medline] LewisCarl SAL, GilleteFerguson I, Ferguson DG (1993) An indirect immunofluorescence procedure for staining the same cryosection with two mouse monoclonal primary antibodies. 

Phrase: "J Neuropathol Exp Neurol 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "1051-1061"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450319:1051 [Intellectual Product]

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] LewisCarl SAL,"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   805   C0036140:Salt [Chemical Viewed Structurally]
   805   C0037494:Salt [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   805   C0206136:Salt [Food,Inorganic Chemical]
   768 E C1537053:salty [Qualitative Concept]
   750 E C0678584:saltiness [Qualitative Concept]

Phrase: "GilleteFerguson I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Ferguson DG (1993"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1275573:dg [Quantitative Concept]

Phrase: ")"

Phrase: "An indirect immunofluorescence procedure for staining"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   753   C0184661:Procedure [Diagnostic Procedure,Therapeutic or Preventive Procedure]
   753   C1948041:Procedure [Therapeutic or Preventive Procedure]
   753   C2700391:Procedure [Activity]
   753   C3274430:PROCEDURE [Health Care Activity]
   753   C3538935:Procedure [Idea or Concept]
   753   C3539779:Procedure [Intellectual Product]

Phrase: "the same cryosection with two mouse monoclonal primary antibodies."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0085188:cryosection [Laboratory Procedure]
Processing 00000000.tx.166: J Histochem Cytochem 41:1273-1278[Abstract/Free FullText] Mercken M, Vandermeern M, Lbke U, Six J, Boons J, Van de Voorde A, Martin J-J et al. 

Phrase: "J Histochem Cytochem 41"

Phrase: ":"

Phrase: "1273-1278"

Phrase: "[Abstract/Free FullText"

Phrase: "] Mercken M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Vandermeern M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Lbke U,"

Phrase: "Six J,"

Phrase: "Boons J,"

Phrase: "Van de Voorde A,"

Phrase: "Martin J-J et al."
Processing 00000000.tx.167: (1992) Monoclonal antibodies with selective specificity for Alzheimer tau are directed against phosphatase-sensitive epitopes. 

Phrase: "(1992"

Phrase: ")"

Phrase: "Monoclonal antibodies with selective specificity"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   806   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   797   C0003264:antibodies specificity [Molecular Function]
   760   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   760   C0746619:monoclonal [Finding]
   745 E C0443640:Specific antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   726 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "for Alzheimer tau"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1720655:Tau [Intellectual Product]
   861   C1947974:Tau [Research Activity]

Phrase: "are"

Phrase: "directed against phosphatase-sensitive epitopes."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0003316:Epitopes [Immunologic Factor]
   760   C0031678:Phosphatase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0332324:Sensitive [Functional Concept]
   760   C1149880:phosphatase [Molecular Function]
   760   C1550474:sensitive [Idea or Concept]
   726   C0439851:Direct [Qualitative Concept]
   726   C1947931:Direct [Qualitative Concept]
Processing 00000000.tx.168: Acta Neuropathol (Berl) 84:265-272[Medline] Nakane PK (1968) Simultaneous localization of multiple tissue antigens using the peroxidase labeled antibody method. 

Phrase: "Acta Neuropathol"

Phrase: "(Berl"

Phrase: ")"

Phrase: "84"

Phrase: ":"

Phrase: "265-272"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nakane PK (1968"

Phrase: ")"

Phrase: "Simultaneous localization of multiple tissue antigens"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the peroxidase labeled antibody method."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]
   756   C0598670:peroxidase labeled antibody [Immunologic Factor]
Processing 00000000.tx.169: A study on pituitary gland of the rat. 

Phrase: "A study on pituitary gland of the rat."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0557651:Study [Manufactured Object]
   744   C2603343:Study [Research Activity]
Processing 00000000.tx.170: J Histochem Cytochem 16:557-560[Medline] Nakayama H, Arima K, Mizushima S, Chui DH, Tabira T (2001) An autopsy case of juvenile Alzheimer's disease with cotton wool plaques. 

Phrase: "J Histochem Cytochem 16"

Phrase: ":"

Phrase: "557-560"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Nakayama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Arima K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Mizushima S,"

Phrase: "Chui DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Tabira T (2001"

Phrase: ")"

Phrase: "An autopsy case of juvenile Alzheimer's disease"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0004398:Autopsy [Diagnostic Procedure]
   748   C0868928:Case [Functional Concept]
   748   C1706255:CASE [Medical Device]
   748   C1706256:Case [Conceptual Entity]

Phrase: "with cotton wool plaques."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   827   C0333463:plaques [Acquired Abnormality]
   793 E C0011389:Plaque [Disease or Syndrome]
   793 E C0332461:Plaque [Finding]
   734   C0440207:Cotton wool [Biomedical or Dental Material]
Processing 00000000.tx.171: Neuropathology 21(suppl):A32 Steiner H, Revesz T, Neumann M, Romig H, Grim MG, Pesold B, Kretzschmar HA et al. 

Phrase: "Neuropathology 21"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0876934:Neuropathology [Biomedical Occupation or Discipline]
   861   C1540677:neuropathology [Pathologic Function]
   861   C1555824:Neuropathology [Intellectual Product]

Phrase: "(suppl):A32 Steiner H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0033727:H+ [Element, Ion, or Isotope]
   812   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441932:H+ [Classification]
   812   C0564385:/h [Quantitative Concept]

Phrase: "Revesz T,"

Phrase: "Neumann M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Romig H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Grim MG,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0439269:mg% [Quantitative Concept]
   861   C1960952:mg % [Quantitative Concept]
   861   C2346927:Mg++ [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: "Pesold B,"

Phrase: "Kretzschmar HA et al."
Processing 00000000.tx.172: (2001) A pathogenic presenilin-1 deletion causes aberrant A42 production in the absence of congophilic amyloid plaques. 

Phrase: "(2001"

Phrase: ")"

Phrase: "A pathogenic presenilin-1 deletion"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C1442161:Deletion [Cell or Molecular Dysfunction]
   812   C1511760:Deletion [Genetic Function]
   812   C1880274:Deletion [Activity]

Phrase: "causes"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0015127:cause [Functional Concept]
  1000   C1314792:Causes [Functional Concept]
  1000   C1524003:Cause [Conceptual Entity]

Phrase: "aberrant A42 production in the absence of congophilic amyloid plaques."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0033268:production [Occupational Activity]
Processing 00000000.tx.173: J Biol Chem 276:7233-7239[Abstract/Free FullText] Tabira T, Chui DH, Nakayama H, Kuroda S, Shibuya M (2002) Alzheimer's disease with spastic paraparesis and cotton wool type plaques. 

Phrase: "J Biol Chem 276"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "7233-7239"

Phrase: "[Abstract/Free FullText"

Phrase: "] Tabira T,"

Phrase: "Chui DH,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1832586:DH [Disease or Syndrome]

Phrase: "Nakayama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Kuroda S,"

Phrase: "Shibuya"

Phrase: "M ("

Phrase: "2002"

Phrase: ")"

Phrase: "Alzheimer's disease with spastic paraparesis"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   806   C0002395:Alzheimer's Disease [Disease or Syndrome]
   806   C1521724:Alzheimer's Disease [Pathologic Function]
   760   C0012634:Disease [Disease or Syndrome]
   704 E C1836721:MALS [Finding]
   704 E C3538764:MALS [Gene or Genome]
   704 E C3540595:MAL [Gene or Genome]

Phrase: "and"

Phrase: "cotton wool type plaques."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0333463:plaques [Acquired Abnormality]
   779 E C0011389:Plaque [Disease or Syndrome]
   779 E C0332461:Plaque [Finding]
Processing 00000000.tx.174: J Neurosci Res 70:367-372[Medline] Uchihara T, Kondo H, Akiyama H, Ikeda K (1995) Single-laser three-color immunolabeling of a histological section by laser scanning microscopy: application to senile-plaque related structures in postmortem human brain tissue. 

Phrase: "J Neurosci Res 70"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "367-372"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Uchihara T,"

Phrase: "Kondo H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Akiyama H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Ikeda K (1995"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]
   827   C3613423:Ikeda [Eukaryote]

Phrase: ")"

Phrase: "Single-laser three-color immunolabeling of a histological section"

Phrase: "by laser scanning microscopy"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
  1000   C0600396:Laser Scanning Microscopy [Laboratory Procedure]
   913   C0600395:Laser Microscopy [Laboratory Procedure]
   827   C0023089:Laser [Manufactured Object]
   827   C0026018:Microscopy [Laboratory Procedure]
   827   C0034606:Scanning [Diagnostic Procedure]
   827   C0441633:Scanning [Diagnostic Procedure]
   827   C0458142:Laser [Phenomenon or Process]
   827   C1023865:Laser [Plant]
   827   C1706315:Laser [Medical Device]
   793 E C2826292:SCAN [Finding]
   755 E C0205288:Microscopic [Qualitative Concept]

Phrase: ":"

Phrase: "application to senile-plaque related structures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0185125:Application [Health Care Activity]
   753   C1947919:Application [Intellectual Product]
   753   C2347934:Application [Intellectual Product]
   753   C3539080:APPLICATION [Quantitative Concept]

Phrase: "in postmortem human brain tissue."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   902   C0444184:Postmortem tissue [Tissue]
   875   C0440744:Human tissue [Tissue]
   861   C0440746:Brain tissue [Tissue]
   861   C0459385:Brain tissue [Body Part, Organ, or Organ Component]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C0040300:Tissue [Tissue]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1547928:Tissue [Intellectual Product]
Processing 00000000.tx.175: J Histochem Cytochem 43:103-106[Abstract/Free FullText] Uchihara T, Nakamura A, Nagaoka U, Yamazaki M, Mori O (2000) Dual enhancement of double immunofluorescent signals by CARD: participation of ubiquitin during formation of neurofibrillary tangles. 

Phrase: "J Histochem Cytochem 43"

Phrase: ":"

Phrase: "103-106"

Phrase: "[Abstract/Free FullText"

Phrase: "] Uchihara T,"

Phrase: "Nakamura A,"

Phrase: "Nagaoka U,"

Phrase: "Yamazaki M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Mori O (2000"

Phrase: ")"

Phrase: "Dual enhancement of double immunofluorescent signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "by CARD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0333562:Deposition [Functional Concept]

Phrase: ":"

Phrase: "participation of ubiquitin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0679823:Participation [Functional Concept]

Phrase: "during formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "of neurofibrillary tangles."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0085400:Neurofibrillary Tangles [Acquired Abnormality]
   966 E C3543859:neurofibrillary tangle [Cell Component]
Processing 00000000.tx.176: Histochem Cell Biol 114:447-451[Medline] Van der Loos CM, Das PK, Van den Oord JJ, Houthoff HJ (1989) Multiple immunoenzyme staining techniques. 

Phrase: "Histochem Cell Biol 114"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "447-451"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Van der Loos CM,"

Phrase: "Das PK,"

Phrase: "Van den Oord JJ,"

Phrase: "Houthoff HJ (1989"

Phrase: ")"

Phrase: "Multiple immunoenzyme staining techniques."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   875   C0021002:Immunoenzyme Techniques [Laboratory Procedure]
   812   C0025664:techniques [Intellectual Product]
   812   C0449851:Techniques [Functional Concept]
Processing 00000000.tx.177: Use of fluoresceinated, biotinylated and unlabelled monoclonal antibodies. 

Phrase: "Use of fluoresceinated,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   882   C1524063:Use of [Functional Concept]
   790   C0042153:use [Functional Concept]
   790   C0457083:Use [Functional Concept]
   790   C1947944:Use [Intellectual Product]

Phrase: "biotinylated"

Phrase: "and"

Phrase: "unlabelled monoclonal antibodies."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   901   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827   C0746619:monoclonal [Finding]
   793 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
Processing 00000000.tx.178: J Immunol Methods 117:45-52[Medline] Verkkoniemi A, Kalimo H, Paetau A, Somer M, Iwatsubo T, Hardy J, Haltia M (2001) Variant Alzheimer disease with spastic paraparesis: neuropathological phenotype. 

Phrase: "J Immunol Methods 117"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   812   C0025663:Methods [Intellectual Product]
   812   C0025664:methods [Intellectual Product]
   812   C0449851:Methods [Functional Concept]
   812   C1517844:Immunol [Organic Chemical,Pharmacologic Substance]
   779 E C0871511:METHOD [Intellectual Product]

Phrase: ":"

Phrase: "45-52"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Verkkoniemi A,"

Phrase: "Kalimo H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Paetau A,"

Phrase: "Somer M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Iwatsubo T,"

Phrase: "Hardy J,"

Phrase: "Haltia"

Phrase: "M ("

Phrase: "2001"

Phrase: ")"

Phrase: "Variant Alzheimer disease with spastic paraparesis"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0002395:Alzheimer's Disease [Disease or Syndrome]
   790   C1521724:Alzheimer's Disease [Pathologic Function]
   753   C0012634:Disease [Disease or Syndrome]

Phrase: ":"

Phrase: "neuropathological phenotype."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0031437:Phenotype [Organism Attribute]
   861   C1285572:Phenotype [Laboratory Procedure]
Processing 00000000.tx.179: J Neuropathol Exp Neurol 60:483-492[Medline]

Phrase: "J Neuropathol Exp Neurol 60"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C1417055:EXP [Gene or Genome]

Phrase: ":"

Phrase: "483-492"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

